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Glycosphingolipide sind wichtige Bestandteile der Zellmembran. Glucosylceramid 
(GlcCer) ist das einfachste Glycosphingolipid und dient als Baustein für die Synthese 
von komplexen Glycosphingolipiden. Defekte in der lysosomalen beta-Glucosidase 1 
(GBA1), welche GlcCer zu Glucose und Ceramid spaltet, führt zu einer Anreicherung 
von GlcCer in den Lysosomen, wodurch das Gaucher-Syndrom, eine schwere Lipid-
Speicherkrankheit, entsteht. Knockout-Mäuse, in denen das Gen für die non-lysosomale 
beta-Glucosidase 2 (GBA2) ausgeschaltet wurde, häufen GlcCer außerhalb der 
Lysosomen an. Dadurch entsteht eine schwere männliche Fertilitätsstörung, die als 
Globozoospermie bezeichnet wird. Die molekularen Mechanismen der Entstehung 
dieser Fertilitätsstörung sind jedoch unbekannt. In meiner Doktorarbeit habe ich zum 
einen untersucht, wo GBA2 in der Zelle lokalisiert ist und zum anderen, warum das 
Fehlen von  GBA2 und damit die Anreicherung von GlcCer in GBA2 Knockout-Mäusen 
zu Globozoospermie führt. Meine Ergebnisse zeigen erstens, dass GBA2 an der 
zytosolischen Seite der Membranen des Golgi-Apparats und des Endoplasmatischen 
Retikulums (ER) assoziiert ist. Zweitens konnte ich zeigen, dass die Anreichung von 
non-lysosomalen GlcCer mit der Funktion des Mikrotubuli-, als auch des 
Aktin-Zytoskeletts interferiert: die Lebensdauer der Mikrotubuli sowie die Rate der 
Aktin-Polymerisation sind in GBA2 Knockout-Mäuse erhöht. Das betrifft v.a. die 
Zytoskelett-Strukturen im Hoden, die für die Ausbildung des Spermienkopfs 
verantwortlich sind: Mikrotubuli in der Spermien-Manschette sind deutlich länger als in 
Wildtyp-Mäusen und die Organisation des filamentösen F-Aktins  in der apikalen 
ectoplasmic specialisation (ES) ist gestört. Zusätzlich wird die Akrosombildung aufgrund 
eines Defekts in Vesikelfusionierung beeinträchtigt. In meiner Arbeit konnte ich zeigen, 
dass die Anreicherung von GlcCer außerhalb der Lysosomen die Lipidorganisation in 
der Plasmamembran erhöht, wodurch die Funktion von Proteinen in der Membran 
gestört wird. Dazu gehören vermutlich auch Proteine, die die Dynamik des Zytoskeletts 
regulieren. Meine Arbeit gibt zum einen Einblick darin, wie GlcCer Signalwege steuert. 
Zum anderen bieten die Ergebnisse meiner Doktorarbeit auch erste Erklärungsansätze 
dafür, wie eine Anreicherung von GlcCer die Spermienentwicklung beeinträchtigen und 
zu männlicher Unfruchtbarkeit führen kann. 
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Glycosphingolipids are important constituents of cellular membranes. 
Glucosylceramide (GlcCer) is the simplest glycosphingolipid and serves as a building 
block for the synthesis of higher-order glycosphingolipids. Defects in the lysosomal 
beta-glucosidase 1 (GBA1), which cleaves GlcCer to glucose and ceramide, causes 
accumulation of GlcCer in lysosomes and, thereby, the severe lipid-storage disorder 
Gaucher disease. Knockout-mice lacking the non-lysosomal beta-glucosidase 2 
(GBA2) accumulate GlcCer outside the lysosomes, resulting in globozoospermia – a 
severe male fertility defect. The molecular mechanisms underlying this fertility defect 
are unknown. In my PhD thesis, I (1) investigated the subcellular localization of GBA2 
and (2) analyzed how the lack of GBA2 causes globozoospermia in mice. First, I 
could demonstrate that GBA2 is attached to the cytosolic side of the endoplasmic 
reticulum (ER) and Golgi membranes. Second, my results revealed that accumulation 
of non-lysosomal GlcCer disrupts cytoskeletal dynamics, affecting both the 
microtubule and actin cytoskeleton: microtubule persistence and the rate of actin 
polymerization are increased in GBA2 knockout-mice. In particular, cytoskeletal 
structures in the testis that shape the sperm head are disturbed: the microtubule 
manchette in sperm of GBA2 knockout-mice persist longer and the F-actin 
organization in the apical ectoplasmic specialization (ES) is disrupted. In addition, 
acrosome formation is impaired due to a defect in vesicle fusion. My results indicate 
that accumulation of GlcCer outside the lysosomes increases lipid stacking in the 
plasma membrane, thereby, interfering with protein function, particularly with the 
function of proteins that control cytoskeletal dynamics. My work provides an insight 
into how GlcCer accumulation affects cellular signaling and, therefore, how the lack 
of GBA2 leads to a defect in male infertility. 
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1. Introduction  
1.1. Glycosphingolipids  
Glycosphingolipids are a class of lipids that can be found in all membranes 
from bacteria to men [1]. Glycosphingolipids control fundamental cellular processes 
such as growth, differentiation, cell-cell and cell-matrix interactions, migration, and 
morphogenesis [2]. They consist of a ceramide backbone and one or more 
carbohydrate head-groups. The ceramide consisting of a sphingosine and a fatty acid 
inserted into the membrane, while the sugar groups face the extracellular space [3]. 
Glucosylceramide (GlcCer) is the simplest glycosphingolipid and serves as a 
precursor for the synthesis of complex glycosphingolipids [4]. 
 
1.2. GlcCer synthesis and function 
Ceramide is synthesized in the endoplasmic reticulum (ER) and transported to 
the trans-Golgi by the ceramide transport protein (CERT) [5]. At the cytosolic side of 
trans-Golgi, GlcCer synthase converts ceramide to GlcCer [6]. GlcCer is transported 
into the Golgi lumen, where it is converted to lactosylceramide (LacCer) by the 
LacCer synthase (Figure 1) [7]. GlcCer can also be transported from the Golgi to the 
ER by the glycolipid transfer protein (GLTP) and/or the phosphoinositol 4-phosphate 
adaptor protein-2 (FAPP2) [8] [9]. LacCer is further converted to complex 
glycosphingolipids in the inner leaflet of the Golgi membrane [1]. GlcCer that is not 
converted to LacCer, functions as an intracellular messenger and controls different 
cellular functions. It has been shown to maintain the skin barrier, control the 
differentiation of keratinocytes [10] [11] [12], and induce axonal growth in 
hippocampal neurons [13] either by controlling the activity of the basic fibroblast 
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growth factor and laminin [14] or by regulating protein transport to the axonal 
membrane [15]. GlcCer has also been proposed to induce cell growth either by 
accelerating DNA synthesis via stimulating thymidine kinase-activity or by 
augmenting the activity of protein kinase C [16] [17]. Last but not least, GlcCer has 
been shown to control vesicular transport of lipids to the cell surface in highly 
polarized cells and cells with tight junctions [18] and to regulate lipid sorting at the 
trans-Golgi [19].  
 
1.3. GlcCer degradation  
GlcCer is degraded to glucose and ceramide by beta-glucosidases [20].  
Beta-glucosidases are glycosyl hydrolases that cleave the beta-1,4 glycosodic 
linkage between the terminal non-reducing residue (the glucose moiety) and the 
ceramide backbone [21]. Until now, three beta-glucosidases have been identified that 
degrade GlcCer: glucocerebrosidase 1 (GBA1), the non-lysosomal beta-glucosidase 
GBA2, and the cytosolic GBA3 (Figure 1) [22] [23] [24]. 
 
 
Figure 1. Synthesis and degradation of GlcCer. Ceramide is glycosylated by the GlcCer 
synthase to form GlcCer. GlcCer is converted to lactosylceramide (LacCer) by the LacCer 
synthase. LacCer is used as a building block to form higher order glycosphingolipids. GlcCer 
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is proteolytically cleaved to glucose and ceramide by the three beta-glucosidases: GBA1, 
GBA2, and GBA3.  
1.4. Beta-glucosidase 1 (GBA1) 
GBA1 is localized in the lysosomes and shows a maximum in enzymatic 
activity around pH 4.0, which can be completely blocked by conduritol B epoxide 
(CBE) [25] [26].  
Macromolecules such as complex lipids are constitutively degraded in the 
endosomes and lysosomes. Defects in this pathway result in debilitating lysosomal 
storage disorders [27]. Deficiencies in GBA1 result in Gaucher disease, the most 
prominent lysosomal storage disorder [28]. Gaucher disease is characterized by 
accumulation of GlcCer in tissue macrophages. Patients suffer from liver and spleen 
enlargement and, in the most severe cases, impairment of the central nervous 
system. Gaucher disease is clinically heterogenous. However, there is no clear 
genotype-phenotype correlation that allows to predict the severity of Gaucher 
disease-pathology [29].   
 
1.5. Beta-glucosidase 2 (GBA2)  
GBA2 is a non-lysosomal beta-glucosidase that shares no sequence 
homology with GBA1 [30]. GBA2 shows a maximum in enzymatic activity around pH 
6.0, which can be blocked by N-butyldeoxynojirimycin (NB-DNJ) [31] [26]. GBA2 has 
been proposed to be a transmembrane protein in the plasma membrane and the ER, 
with the N terminus and the catalytic domain being located on the extracellular side 
or in the lumen of the ER [32]. However, we have recently demonstrated that GBA2 
is not a transmembrane protein but rather membrane-associated at the ER and Golgi 
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with both the N and the C termini facing the cytoplasm [26]. This implies that the site 
for GBA2-mediated degradation of non-lysosomal GlcCer is cytosolic. 
GBA2 is ubiquitously expressed with highest expression levels in the testis 
and brain followed by liver, heart, spleen, and skin [30]. To study GBA2 function in 
vivo, a GBA2 knockout-mouse model was generated using a gene targeting 
approach that deleted exons 5 –10 [30]. In the absence of GBA2, GlcCer 
accumulated predominantly in tissues with high GBA2 expression levels, e.g. testis 
and brain. While female GBA2 knockout-mice appeared to be phenotypically normal, 
male GBA2 knockout-mice were sub-fertile due to a defect during spermatogenesis 
called globozoospermia [30]. A detailed description of this defect is the subject of 
chapter 1.7.  
Recently, it has been shown that GBA2 knockout-mice also display a liver 
phenotype: liver regeneration after partial hepatectomy was impaired and has been 
attributed to a defect in cytokine and growth factor-mediated signaling pathways [33]. 
Mutations in the GBA2 gene in humans have been associated with autosomal 
recessive cerebellar ataxia (ARCA) and hereditary spastic paraplegia (HSP) due to 
cerebellar atrophy, which are both characterized by lack of limb coordination [34] 
[35].  
Taken together, GBA2 seems to control different physiological functions. 
However, the underlying molecular mechanisms are ill defined.  
 
1.6. Spermatogenesis  
The primary phenotype of GBA2 knockout-mice is male sub-fertility [30]. Thus, 
it is important to investigate the role of GBA2 in spermatogenesis.  The testis consists 
of seminiferous tubules, where spermatogenesis occurs in waves (Figure 2a). In the 
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mouse, each wave lasts for about 35 days and is characterized by a sequence of 
developmental stages (I to XIV) [36]. The blood-testis barrier (BTB) divides the 
seminiferous tubule into a basal and an adluminal part (Figure 2d). The BTB, also 
called basal ectoplasmic specialization, is a specialized junction formed by Sertoli 
cells close to the basal membrane. They are characterized by actin filaments 
arranged perpendicular to the plasma membrane, which are sandwiched by the ER 
cisternae on one side and the plasma membrane of the Sertoli cells on the other side 
[37]. The BTB restricts the flow of molecules from the basal into to the adluminal 
compartments, thereby, creating a microenvironment that is conducive for the 
development of germ cells [38].  Furthermore, the BTB also acts as an immunological 
barrier by preventing entry of antibodies generated against proteins expressed on 
developing germ cells [39]. The BTB confers cell polarity in the seminiferous 
epithelium via the recruitment of polarity-complex proteins to the BTB, which is 
crucial for spermatogenesis [40]. At birth, spermatogenesis starts at the basal lamina 
of the seminiferous epithelium with diploid spermatogonia. Spermatogonia undergo 
mitotic divisions to form primary spermatocytes, which cross the BTB in the 
preleptotene phase of meiosis I. Upon reaching the adluminal compartment, primary 
spermatocytes complete meiosis I and II to form secondary spermatocytes, which 
differentiate into round spermatids at puberty. During spermiogenesis, the round 
haploid spermatids undergo dramatic morphological rearrangements to form 
elongated sperm (Figure 2d) [41]. The sperm head is connected to the Sertoli cell via 
another testis-specific junction, the apical ectoplasmic specialization (ES) [42]. The 
function of the ES in sperm development is described in chapter 1.8.  
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Figure 2. Spermatogenesis in the mouse.  (a) Schematic representation of mouse testis 
with longitudinally arranged seminiferous tubules. (b) Light microscopic view of a cross 
section through the testis. (c) Schematic diagram of a cross section through a single tubule, 
showing Sertoli cells (green), different stages of developing spermatogonia (light blue), the 
basal lamina (brown), and Leydig cells (dark blue) [43]. (d) Schematic representation of the 
first wave of spermatogenesis. It starts at birth (P0) and ends with the release of mature 
sperm (P34). At P5, diploid spermatogonia (light blue) undergo mitotic divisions to form 
primary spermatocytes (pink) followed by meiosis I to form secondary spermatocytes 
(orange). At puberty (P27 – P29), secondary spermatocytes undergo meiosis II to form round 
haploid spermatids (red). During spermiogenesis, round spermatids dramatically change 
their morphology to form elongated sperm. The position of the blood-testis barrier (BTB) and 
the apical ectoplasmic specialization (ES) is shown in red.  
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1.7. Globozoospermia  
Globozoospermia results from a defect during sperm development and is 
characterized by round-headed sperm with a severely deformed acrosome [44]. As 
mentioned above, GBA2 knockout-males are sub-fertile due to globozoospermia: the 
heads of wild-type sperm are sickle-shaped with a well-formed acrosome, whereas 
heads of GBA2 knockout-sperm are round, contain no or a malformed acrosome, and 
the mitochondria in the sperm flagellum are displaced (Figure 3) [30]. Recently, men 
with mutations in the GBA2 gene have been diagnosed with bilateral testicular 
hypotrophy and their sperm displayed severe head and acrosome deformation [35]. 
However, the molecular mechanisms underlying the defects in sperm development in 
the absence of GBA2 are not known.  
 
 
 
 
 
 
 
 
 
Figure 3. Wild-type and GBA2 knockout-sperm head morphology. Left: electron 
micrograph of sperm from a wild-type (+/+) mouse with a normal, sickle-shaped head. 
Right: electron micrograph of a GBA2 knockout-sperm (-/-) with a round-shaped head. The 
electron-dense region represents the sperm nucleus. Scale bars: 500 nm [30].  
 
The prominent feature of globozoospermia is a defect in acrosome formation 
[45]. The acrosome is derived from the Golgi [46]. Vesicles emanate from the 
trans-Golgi and fuse with the nuclear membrane to form the acrosome at the anterior 
end of the sperm head [47]. A number of proteins have been identified that regulate 
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acrosome formation. They mainly control vesicle trafficking and fusion or anchoring of 
the acrosome to the nuclear membrane [46] [47] [48] [49] [50] [51]. Knockout mice for 
the underlying genes all display globozoospermia.  
The DPY19L2 protein is a transmembrane protein in the nuclear envelope. In 
DPY19L2 knockout-mice, the acrosome detaches from the nuclear membrane, 
whereby, shaping of the sperm head is abolished and acrosomal vesicles are 
eliminated [52].  
Hrb (HIV-1 Rev binding protein) is associated with the outer membrane of the 
proacrosomal vesicles emanating from the Golgi. In Hrb knockout-mice, vesicle 
fusion leading to acrosome formation is abolished, indicating that Hrb is important for 
vesicle docking and/or fusion [46]. 
GOPC (Golgi-associated PDZ and coiled coil motif containing protein) is 
localized at the trans-Golgi of developing sperm. GOPC knockout-sperm display a 
defect in proacrosomal vesicle fusion, nuclear shaping, and in the alignment of 
mitochondria along the flagellum [48]. A similar phenotype is observed in PICK1 
(protein interacting with C-kinase) knockout-mice [49]. PICK1 has been proposed to 
interact with GOPC and together, they seem to coordinate the formation of 
proacrosomal vesicles from the trans-Golgi [49].  
Vps54 is a vesicular protein that controls vesicular sorting [53]. Together with 
GARP (Golgi associated retrograde protein), it is involved in vesicle transport from 
the endosomes to the trans-Golgi [54].  Mutations in the Vps54 gene render 
proacrosomal vesicles incapable of fusing to form the acrosome [50].  
ZPBP1 (zona pellucida binding protein 1) is a protein associated with the inner 
acrosomal membrane that binds to the zona pellucida, the egg coat, during 
fertilization [55]. Mice lacking ZPBP1 fail to form a compact acrosomal structure, 
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resulting in a dilated acrosome overlying the sperm head. The dilated acrosome is 
fragmented and ingested by the Sertoli cells [51]. Thus, sperm heads are round, lack 
an acrosome, and are therefore, incapable of fertilizing an oocyte.  
 
1.8. The Cytoskeleton: machinery for sperm-head shaping 
 Globozoospermia not only involves a defect in acrosome formation. In many 
cases, the shaping of the sperm head is also affected, indicating that the two 
processes are linked. During spermatid elongation, the sperm head is shaped at the 
posterior end by a manchette of microtubules and at the anterior end by the apical 
ES (Figure 4) [56] [57]. The microtubule manchette consists of a perinuclear ring that 
is supported by numerous vertically arranged microtubules. The constrictive 
downward movement of the manchette shapes the postacrosomal region of the 
sperm head [58] [59]. The other cytoskeletal structure that shapes the sperm head is 
the apical ES, a testis-specific adherence junction between the developing spermatid 
head and the Sertoli cell (Figure 4). Similar to the BTB, this ES consists of F-actin 
supported by the endoplasmic reticulum and plasma membrane of the Sertoli 
cells [37]. F-actin at the ES forms bundles or hoops around the sperm head. Since 
F-actin in the ES is devoid of myosin, the ES cannot generate contractile forces [60]. 
However, the polymerization and depolymerization of F-actin, initiated by actin 
severing proteins like gelsolin [61] and proteins that facilitate polymerization like 
profilin-3 [62], causes tread milling of the F-actin containing hoops. Thereby, 
constriction forces are generated that shape the acrosomal region of the sperm 
head [57]. These forces are transduced to the spermatid head via the acrosplaxome, 
an F-actin/keratin 5 containing cytoskeletal plate that anchors the acrosome to the 
spermatid head [57]. Together, the microtubule manchette and the apical ES act as 
endogenous constrictors that steer spermatid elongation and shape the sperm 
head (Figure 4).  
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Figure 4. Schematic representation of the structural components that shape the sperm 
head. The elongated spermatid (blue) is attached to the Sertoli cell (brown) via the apical 
ectoplasmic specialization (ES). The F-actin hoops (orange) that form the ES act as a 
scaffold and contribute to the shaping of the acrosomal region of the spermatid head. The 
microtubules (purple) form a manchette, consisting of a perinuclear ring supported by 
longitudinal microtubules around the spermatid neck that shape the postacrosomal region of 
the sperm head. The acroplaxome (red) anchors the acrosome to the spermatid nucleus. 
The perinuclear ring of the manchette is separated from the acroplaxome by the belt groove. 
The spermatid flagellum is shown in green. Diagram adapted from [63] and [64].     
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Defects in the assembly and removal of the microtubule manchette have been 
shown to affect the morphology of the sperm head [63]. The p80 subunit of katanin, a 
microtubule-severing protein, controls the removal of the microtubule manchette. In 
katanin p80 knockout-mice, removal of the microtubule manchette is abolished, 
resulting in abnormal sperm-head morphology [63].  
Clip 170 is a microtubule plus-tip binding protein that is localized to the 
perinuclear ring of the microtubule manchette and maintains the structural integrity of 
the manchette [65]. In the absence of Clip 170, the microtubule manchette is 
misaligned, leading to a defect in sperm-head formation [65].   
Mutations in genes that control microtubule dynamics have also been shown 
to disrupt the microtubule network in Sertoli cells. A mutation in the KATNAL1 gene, 
which encodes a microtubule-severing protein, disrupts the microtubule dynamics in 
Sertoli cells, resulting in infertility due to premature release of spermatids from the 
seminiferous epithelium [66]. 
The apical ES contributes to the shaping of the spermatid head, but also 
assists in positioning and moving the developing sperm across the seminiferous 
epithelium, which prevents premature release of immature sperm [67]. Extensive 
research on the molecular composition of the ES has identified several actin binding 
and regulatory proteins.   
Chemical disruption of the actin cytoskeleton in the ES by cytochalasin D 
treatment has been shown to cause premature release of immature sperm, resulting 
in infertility [68].  
The junctional adhesion molecule-C (JAM-C) is a transmembrane protein 
expressed in spermatogenic cells. JAM-C interacts with JAM-B at the ES in Sertoli 
cells, thereby, controlling the communication between Sertoli and germ cells. JAM-C 
Introduction 
 
12 | P a g e  
 
is also responsible for recruiting the cell-polarity complex, Par6-Cdc-42-PKCλ, to the 
ES [69]. Spermatids from JAM-C knockout-mice lack cellular polarity, which is 
required for spermatid differentiation. As a consequence, these mice fail to produce 
mature sperm [69].  
Abnormal bundling of actin fibers at the apical ES has been shown to cause 
infertility due to malformations in the sperm head. Nectin-2 is exclusively expressed 
in Sertoli cells and is localized at the junctions between Sertoli cells and between 
Sertoli and germ cells. Nectin-2 recruits and/or maintains F-actin bundles at the ES. 
In the absence of nectin-2, the ES fails to form due to the lack of actin bundling. 
Consequently, sperm heads are deformed and are unable to fertilize the oocyte [70]. 
 
1.9. Aim of the thesis    
 The physiological function of the GBA2, a non-lysosomal beta-glucosidase, is 
ill-defined. Accumulation of GlcCer in GBA2 knockout-mice causes globozoospermia 
and, thereby, male infertility. However, the underlying molecular mechanism is not 
known. Thus, the aim of my PhD thesis is to investigate the molecular mechanisms 
underlying the development of globozoospermia in GBA2 knockout-mice. 
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2. Materials  
2.1. Antibodies  
2.1.1. Primary antibodies  
ANTIBODY ORIGIN 
DILUTION 
MANUFACTURER 
ICC WB 
Calnexin rb 1:100 1:20000 abcam 
GBA2-4A12 rt 1:50 1:20 E. Kremmer (HZ München) 
GBA2-4D7 rt 1:50 1:20 E. Kremmer (HZ München) 
GBA2-2F8 rt 1:50 1:20 E. Kremmer (HZ München) 
GBA2-5A8 rt 1:50 1:20 E. Kremmer (HZ München) 
Polyclonal GBA2 rb 1:1000 1:2000 Y. Yildiz (Yildiz et al., 2006) 
beta-tubulin-CY3 ms 1:500 - Sigma #C4585 
HA  1:1000 1:10,000 Roche #11867431001 
beta-tubulin III rb 1:500 1:1000 Covance #MRB-435P 
BrdU ms 1:200 - Invitrogen #MP35128 
GM-130 ms 1:100 - BD Transduction Labs #610822 
Giantin rb 1:1000 - Abcam #ab24586 
Lamp1 rb 1:200 - Abcam #ab24170 
Sox9 rb 1:1000 - Millipore #AB5535 
Cdc-42 rb - 1:1000 Abcam #ab64533 
Rac1 ms - 1:1000 Abcam #ab33186 
 
2.1.2. Secondary antibodies  
ANTIBODY ORIGIN 
DILUTION 
MANUFACTURER 
ICC WB 
d α rb Cy3 d 1:250 - Dianova 
d-α- rtCy3 d 1:250 - Dianova 
gt α ms Dylight 488 gt 1:100 - abcam 
d α rb IRDye680 d - 1:20000 LI-COR Bioscience 
gt α rt IRDye800 gt - 1:20000 LI-COR Bioscience 
d α ms IRDye800 d - 1:20000 LI-COR Bioscience 
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2.1.3. Dyes 
DYE 
DILUTION 
MANUFACTURER 
ICC WB 
Phalloidin  1:500 - Molecular Probes #A12379 
MitoTracker 0.5 µM - Molecular Probes #M22426 
Peanut lectin 1:100 - Sigma #7381 
DAPI 1:10,000 1:10,000 Molecular Probes #D1306 
2.2. Bacterial strains and Cell lines  
The Escherichia coli XL1-Blue (Bullock et al. 1987) was used to amplify 
plasmid DNA. 
2.3. Plasmids 
Lifeact-GFP and EB3-mCherry were kindly provided by Dr. Roland Wedlich-
Söldner and Dr. J.Victor Small, respectively.  
3. Methods  
GBA2 knockout-mice were generated as mentioned in [30]. All experiments 
performed with animals were in accordance with the relevant guidelines and 
regulations. The generation of antibodies and stable HEK293 cell lines is described 
in [26].  
3.1. Cell culture  
3.1.1. Isolation of sperm and male germ cells 
Sperm were isolated by incision of the cauda epididymis in modified TYH 
medium containing 138 mM NaCl, 4.8 mM KCl, 2 mM CaCl2, 1.2 mM KH2PO4, 1 mM 
MgSO4, 5.6 mM glucose, 0.5 mM sodium pyruvate, 10 mM L-lactate, pH 7.4.  
Materials and Methods 
 
15 | P a g e  
 
For isolation of germ cells, testes were decapsulated and incubated in 1 ml 
Hank’s Balanced Salt Solution (HBSS) (20 mM HEPES, 137 mM NaCl, 5.4 mM KCl, 
0.3 mM Na2HPO4, 0.4 mM KH2PO4, 1.2 mM MgSO4, 1.3 mM CaCl2, 6.6 mM sodium 
pyruvate, 0.05% lactate, 5.6 mM glucose, pH 7.2) containing 0.5 mg/ml Collagenase 
type IA (Sigma) for 30 min at 32 °C. The dissociated interstitial cells were removed 
by two washing steps with HBSS. The seminiferous tubules were then incubated in 
1 ml HBSS containing 0.5 mg/ml Trypsin type XIII (Sigma) and 1 µg/ml DNaseI 
(Applichem) for 10 min at 32 °C. Cell aggregates were sheared gently with a Pasteur 
pipette. The dispersed seminiferous cells were washed twice by centrifugation at 
200 x g for 5 min at room temperature. The final cell pellet was resuspended in HBSS 
and filtered through a Nylon mesh (40 µm pore size). 
3.1.2. Isolation of P7 Sertoli cells  
Seminiferous tubules were isolated from testis of 7 days old mice (P7) by 
removal of the tunica albuginea. The tubules were treated with 1 mg/ml collagenase 
(Sigma) at 37°C in a shaker for 8 min. The digestion was stopped by addition of 
DMEM/GlutaMax medium (Invitrogen) containing 10% FCS (Biochrom). The cell 
suspension was centrifuged at 400 x g for 8 min, the pellet was re-suspended in 
DMEM/GlutaMax medium containing 10% FCS and 0.5 mg/ml trypsin (Sigma) and 
0.22 mg/ml EDTA (Sigma), and incubated in a shaker at 37°C for 5 min. The reaction 
was stopped by adding medium. The cell suspension was then treated with 1 µg/ml 
DNase I (Applichem) in a shaker at 37°C for 5 min. Afterwards, cells were centrifuged 
at 600 x g for 10 min, and re-suspended in medium containing 70 IU/ml penicillin, 
70 µg/ml streptomycin, 100 mM sodium pyruvate, and 200 mM L-glutamine (all Life 
technologies). Cells were seeded at a density of 5 x 104 cells/5 cm cell culture plate 
(Greiner bio-one) and used on the 5th day for experiments.  
In order to maintain the intercellular junctions of the isolate, the seminiferous 
tubules were treated with 1 mg/ml dispase (Stem cell technologies, #07923) instead 
of collagenase and trypsin in a shaker at 37°C for 30 min. After treatment the cells 
were centrifuged, re-suspended in fibroblast growth medium (see 3.1.3) and plated 
on poly-L-lysine coated glass coverslips.  
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3.1.3. Isolation of dermal fibroblasts 
Dermal fibroblasts were isolated from mouse tails using collagenase digestion. 
Tail pieces were incubated in fibroblast growth medium containing 0.1 mg/ml 
collagenase (Sigma) for 3h, 37 °C, and 5% CO2. After digestion, the supernatant was 
centrifuged for 5 min, 600 x g at room temperature. The cell pellet was re-suspended 
in fibroblast growth medium; cells were plated on cell culture plates, and cultured at 
37°C, 5% CO2. After 24 h, the medium was changed.  
Fibroblast growth 
medium 
DMEM/GlutaMax containing 10% FCS, 100 mM sodium 
pyruvate, 200 mM L-glutamine, 70 IU/ml penicillin, 70 µg/ml 
streptomycin. 
3.1.4. Immunocytochemistry (ICC)  
 Cells were fixed in 4% paraformaldehyde at room temperature for 10 min. To 
preserve the cytoskeleton, cells were fixed with PHEM for 15 min at RT. After 
washing with PBS (1.5 mM KH2PO4, 2.7 mM KCl, 6.5 mM Na2HPO4, 137 mM NaCl, 
pH 7.4), a quenching step was introduced by incubating the cells for 10 min in 25% 
glutaraldehyde and 50 mM NH4Cl in PBS at room temperature. Sperm were 
immobilized on microscope slides and fixed with 4% paraformaldehyde at room 
temperature for 10 min. Before blocking, all cells were washed 3 x with PBS.  To 
block unspecific binding sites, cells were incubated for 1 h with blocking buffer (0.5% 
Triton X 100 and 5% ChemiBLOCKER (Millipore) in 0.1 M phosphate buffer, pH 7.4). 
Primary antibodies were diluted in blocking buffer and incubated 1 h at room 
temperature. Fluorescent secondary antibodies were diluted in blocking buffer 
containing 0.5 µg/µl DAPI (Invitrogen) and incubated for 1 h in the dark. Pictures 
were taken on a confocal microscope (Olympus FV1000). For the analysis of 
cytoskeletal structures in dermal fibroblasts, cells were seeded on multi-pattern 
fibronectin coated CYTOO chips (#10-900-13-06, CYTOO Cell Architects). 
PHEM BUFFER STOCK (PH 7.0) 1X PHEM 
2 mM MgCl2 1x PHEM buffer 
10 mM EGTA 0.1 % (v/v) Triton X-100 (Roth) 
25 mM HEPES 0.25 % (w/v) glutaraldehyde (Sigma) 
60 mM PIPES 3.7 % (w/v) PFA/sucrose 
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3.1.5. Immunohistochemistry (IHC)  
Testes were fixed overnight with 4% paraformaldehyde/PBS, cryo-protected in 
10% and 30% sucrose, and afterwards embedded in TissueTec (Sakura Finetek). 
Thin cross-sections of (16 µm) thickness were made in a cryotome (Microm HM 560). 
Immunofluorescent labeling was performed as described above except that the 
primary antibody was incubated overnight in a humidified chamber at room 
temperature. 
3.1.6. Unroofing of HEK293 cells  
 HEK293 cells were transfected with a membrane-anchored GFP (CAAX). For 
unroofing 1 ml of stabilization buffer (30 mM HEPES pH 7.4, 70 mM KCl, 5 mM 
MgCl2, 3 mM EGTA, 1 mM DTT) was added and cells were sonicated once for 
0.1 sec with a pulse amplitude of 5% in a sonifier (Branson sonifier 450). Afterwards, 
cells were gently washed to remove debris and stained with antibodies.  
3.1.7. Fluorescence protease protection (FPP) assay  
The assay was performed as described in [71].  
3.1.8. Transfection of mouse fibroblasts 
1x106 mouse fibroblasts were resuspended in 100 µl transfection buffer (Neon 
transfection system, Life technologies) and 4 µg of plasmid DNA was added. Using a 
microporator mini (Digital Bio Technology, MP-100), 10 µl of the cell supsension were 
subjected to two pulses (20 ms each) of 1000 V and afterwards transferred to poly-L-
Lysine-coated glass-bottom dishes (Mat Tek, #P35G-1.5-20-C). A total of 30 µl of 
cells were electroporated. The cells were allowed to grow overnight at 37°C and 5% 
CO2 in medium.  
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3.1.9. Live-cell imaging 
Cells were imaged 24 h after transfection using the DeltaVision Core 
microscope (Applied Precision, Inc.). Images were acquired every 3 s with 
200-500 ms exposure time over 5 min. 
3.1.10. Analysis of microtubule dynamics  
Image analysis was performed using the track-points function of Metamorph 
(version 7.0, Molecular Devices Corporation). A microtubule track was followed from 
the first frame an EB3-labelled microtubule plus-tip appeared until the last frame, 
when the plus-tip was no longer visible. Data for velocity (microtubule advance-rate) 
and distance (microtubule persistence) were calculated. Per cell, a minimum of 10 
microtubule tracks and 7 cells per cell line were analyzed. In total, for each genotype, 
cells from 3 animals were analyzed.     
3.1.11. Measurement of microtubule manchette  
 Isolated germ and Sertoli cells were labeled with a beta-tubulin antibody to 
visualize the manchette and DAPI to label the DNA in the sperm head. Images were 
taken using an Olympus FV1000 confocal microscope and the length of individual 
sperm manchettes was measured using ImageJ (version 1.46m). A minimum of 7 
cells and three animals per genotype were analyzed.  
3.1.12. Analysis of actin structures 
Mouse fibroblasts were plated on CYTOO chips (CYTOO Cell Architects, 
#10 900-13-06) placed in a 35 mm cell culture plate and labeled with Phalloidin and 
DAPI. Images were taken using an Olympus FV1000 confocal microscope. Filopodia 
(slender actin-protrusions) and lamellipodia (wave-like actin extensions) structures 
were manually counted and expressed as number of filopodia or lamellipodia per cell.   
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3.1.13. Proliferation assay  
Fibroblasts were seeded at a density of 4x104 cells/well and allowed to grow 
overnight. Cells were labelled with BrdU (Invitrogen #00-0103, diluted 1:100 from 
concentrate of 10:1 5-bromo-2'-deoxyuridine and 5-fluoro-2'-deoxyuridine) in 
fibroblasts growth medium for 8 hours at 37°C, 5% CO2, and fixed with 70% ethanol 
for 10 min at room temperature. Before performing ICC using an anti-BrdU antibody 
cells were treated with 1.5 M HCl for 30 min. BrdU labeled nuclei were counted using 
the ImageJ (version 1.46m) cell counter plug-in. The proliferation rate was calculated 
by determining the ratio of proliferated cells to the total number of cells. Seven 
animals per genotype were analyzed. 
3.1.14. Wound-healing assay 
Silicone cell culture-inserts (Ibidi, #80209) with a defined cell-free gap 
(width = 500 µm) were placed in 35 mm cell culture dishes. 4 x 104 cells were 
transferred into each of the culture inserts and incubated at 37°C, 5% CO2 for 2 h. 
Afterwards, inserts were removed and cells were washed with PBS (1.5 mM KH2PO4, 
2.7 mM KCl, 6.5 mM Na2HPO4, 137 mM NaCl, pH 7.4). Fresh medium was added 
and a phase contrast image was taken (t = 0 h) using the Nikon eclipse (TE 2000-S) 
microscope.  An image of the same region was taken every 2 h (t = 2, 4, 6, 8 h). The 
area of the cell-free gap was measured using ImageJ (version 1.46m) and the speed 
of migration was calculated.  
3.1.15. Isolation of giant plasma-membrane vesicles (GPMVs) 
Giant plasma-membrane vesicles (GPMVs) have been isolated as described 
elsewhere [72]. In brief, dermal fibroblasts were incubated with GPMV buffer (10 mM 
HEPES, 150 mM NaCl, 2 mM CaCl2, pH 7.4) containing 2 mM NEM for 1-2 h at 
37°C, 5% CO2. The supernatant was centrifuged for 10 min at 2,000 x g and room 
temperature to pellet cell debris and intact cells. The resulting supernatant was 
subjected to high-speed centrifugation for 1 h at 45,000 x g and 4 °C to pellet the 
vesicles. The pellet was re-suspended in GPMV buffer.  
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3.1.16. Fluorescence spectroscopy  
Measurements were performed in a quartz cuvette using the FluoroMax-3 
Spectrofluorometer (Horiba Jobin yvon). The emission spectrum was recorded from 
400 nm to 500 nm at 385 nm excitation to detect the lipid resonance-peak at 425 nm. 
All samples were normalized to the lipid resonance-peak for the GPMV buffer. 
GPMVs were labeled with 5 µM laurdan (6-Dodecanoyl-2-
Dimethylaminonaphthalene, Molecular Probes, #D250) for 20 min at 23 °C. 
Measurements were performed at 350 nm excitation and fluorescence emission was 
recorded from 400 to 600 nm. All measurements were done at 23 °C. GP value was 
calculated according to the following equation where  is the intensity of emitted light 
at wavelength x.  
 
3.2. mRNA expression analysis 
Total RNA isolation and reverse transcription to obtain cDNA was performed 
according to the manufacturer’s instructions (Nucleo-Spin RNA II: Macherey & Nagel, 
Düren, Germany; Superscript III: Invitrogen).  
3.2.1. Quantitative real-time PCR  
 
For qRT-PCR, two master mixes were prepared:   
MIX I MIX II 
 1 µl of a 5 µM dilution of each 
primer of one primer pair 
 
 12.5 µl SYBR Green Supermix 
(Biorad) 
 1 µl of the 1:5 cDNA 
dilution 
 
 10.5 µl H2O 
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qRT-PCR was performed for Cdc-42, Rac1, RhoA, Nectin2, and Vinculin, and 
for the housekeeping genes Tfrc and Gusb. Primers for qRT-PCR were tested for 
efficiency before use. Efficiency tests include dilution of template cDNA from 1:1 up 
to 1:1000. The slope obtained from plotting the individual CT values is used to 
calculate primer efficiency (E = 10-1/slope). Primers used for real-time PCR showed at 
least 90% efficiency. Different annealing temperatures were used for the primers. 
 
PRIMER 
FORWARD 
PRIMER 
REVERSE 
PRIMER 
PRIMER 
NUMBER 
ANNEALING 
TEMPERATURE 
(°C) 
Cdc-42 
ACCCAACCATGC
GTCCCC 
GTCCTCAGCTTC
TCCGCC 
C2076/C
2077 
62 
Rac1 
TTTCCCCAGCTT
TGGGTGG 
TCCCACCACCAC
ACACTTG 
C2080/C
2081 
51 
RhoA 
CGTGGATGCGT
TCTTGAGC 
ATGGAGAGAACC
GACGGAG 
C2078/C
2079 
59 
Nectin2 
GAGAGGCCAAA
GATACTCAG 
CCAAGGTACCAG
TTGTCATC 
C1877/C
1878 
59 
Vinculin 
TGTTCAGACCAC
TGAGGATC 
TCAGCCTCATCG
AAGGTAAG 
C2082/C
2083 
59 
 
The reaction was set up in duplets for each gene and each template (mouse 
GBA2 wild-type and knockout testis cDNA). Additionally, a non-template control was 
set up for each primer pair. All qRT-PCR experiments were performed in the BioRad 
I-cycler with an IQ5 optical system. Data was analyzed using the BioRad IQ5 optical 
system software and calculated according to the delta-delta-CT method [73]. 
The following PCR program was used:  
 
 
CYCLE STEP 
TEMPERATURE 
(°C) 
TIME 
(SEC) 
Denaturation Step I 95 180 
Denaturation 
Annealing 
Extension 
(35X) 
Step I 95 10 
Step II see above 30 
Step III 72 30 
Denaturation Step I 95 60 
Melt curve 
Step I 55 60 
Step I 55 30 
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After running the cycles, a melt-curve analysis was performed to detect 
non-specifically amplified products. mRNA expression-levels for wild-type and 
knockout were normalized to the housekeeping genes. 
3.3. Biochemistry 
3.3.1. Protein preparation 
All steps were performed at 4 °C in the presence of mammalian protease 
inhibitor cocktail (mPIC, Sigma Aldrich). Tissues or cells were homogenized in a 10-
fold surplus (v/w) of hypotonic buffer (10 mM HEPES, 0.5 mM EDTA, pH 7.4) using 
an Ultra-thurrax (IKA) and three pulses (20 s each) of sonification (Branson sonifier). 
The suspension (total lysate) was centrifuged for 10 min at 1,000  g. The 
supernatant (PNS, post-nuclear supernatant) was used for activity assays.  For 
Western-blot analysis the tissue was homogenized in detergent containing buffer (10 
mM Tris/HCl pH 7.6, 140 mM NaCl, 1 mM EDTA, 1 % Triton X-100). After 30 min of 
incubation on ice, the suspension was centrifuged for 5 min at 10,000xg. The 
supernatant was used for experiments. The protein concentration was estimated 
using the bicinchoninic acid (BCA) test. Aa protein standard gamma-globulin protein 
was used. The absorbance of the protein of interest and the standards was 
measured at 570 nm in the Packrad Fusion Instrument plate reader. The protein 
concentration of the sample was calculated using the linear regression of the protein 
standard.     
3.3.2. SDS-PAGE and Western-blot analysis 
SDS-sample buffer (4x; 200 mM Tris/HCL pH 6.8, 0.04 % bromophenol blue, 4 
% beta-mercaptoethanol, 8 % SDS, 50 % glycerine) was added to all samples (final 
1x) and heated for 5 min at 95 °C prior to loading onto SDS-PAGE (sodium dodecyl 
sulfate polyacrylamide gel electrophoresis). The SDS-PAGE was performed in 
running buffer (final 1x; 10x: 250 mM Tris, 1.92 M glycine, 1 % SDS) at 180 V and 
120 mA. As protein standard the Novex prestained protein ladder (Invitrogen; 3.5–
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260 kDa) was used. For Western-blot analysis, proteins were transferred onto PVDF 
membranes (Immobilon-FL, Millipore), probed with antibodies, and analyzed using 
the Odyssey Imaging System (LI-COR). Quantification of the Western blots was done 
using ImageJ (version 1.46m).  
3.3.3. G-/F-Actin assay 
The assay was performed according to the manufacturer’s protocol (#BK037, 
Cytoskeleton).  
3.3.4. Fluorescence-based GBA activity assays 
The assay has been performed as described previously [26]. Briefly, cleavage 
of 4-MU-beta-D-glucopyranoside (Sigma Aldrich) was monitored in real-time in a 
Fluostar Omega reader (BMG labtech) at 29 °C using the filter pair 355 nm/460 nm 
for excitation and emission, respectively. The assays were performed in 384-well 
plates (Greiner) in the plate mode. Per well, 25 µl of lysate containing 20 µg of total 
protein were used. To discriminate between GBA1 and GBA2 activity, 30 µM CBE 
(Conduritol B epoxide, Sigma Aldrich), an inhibitor for GBA1, or 10 µM NB-DNJ (N-
butyldeoxynojirimycin, Sigma Aldrich), an inhibitor for GBA2, were included. The pH 
of the protein lysates and the 4-MU-beta-D-glucopyranoside solution were adjusted 
by diluting with McIlvaine buffer (0.1 M citric acid and 0.2 M Na2HPO4). The assay 
was initiated by adding 5 µl of 4-MU-beta-D-glucopyranoside (10 mM) resulting in a 
final concentration of 1.67 mM. The hydrolysis of 4-MU-beta-D-glucopyranoside was 
monitored and recorded as a change of relative fluorescence units (rfu) per minute. 
Each analysis was performed as a quadruplicate in parallel. Per genotype, tissues or 
cells from three animals were analyzed if not otherwise stated.  
3.4. Lipid analysis 
3.4.1. Lipid analysis using thin-layer chromatography (TLC) 
For lipid extraction, dermal fibroblasts from GBA2 wild-type (+/+) and 
knockout-mice (-/-) were grown until confluency, washed with PBS (1.5 mM KH2PO4, 
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2.7 mM KCl, 6.5 mM Na2HPO4, 137 mM NaCl, pH 7.4), and harvested using 
trypsin/EDTA in medium. Cells were pelleted for 7 min at 700 x g and room 
temperature. Afterwards, cells were lysed in 1 ml distilled water with three pulses (30 
s each) of sonification (Branson sonifier). Lipids were extracted for 24 h at 37 °C in 
chloroform/methanol/water (10/5/1, v/v/v). For a better analysis of glucosylceramide, 
glycerophospholipids were degraded by alkaline hydrolysis with 125 mM sodium 
hydroxide for 2 h at 37 °C. After neutralization with acetic acid, lipid extracts were 
desalted by reversed-phase chromatography and separated into acidic and neutral 
glycosphingolipids as described previously [74] [75]. 
For separation of neutral lipids by thin layer chromatography (TLC), 1 mg of 
total protein was applied to prewashed thin layer Silica Gel 60 (Merck, Darmstadt, 
Germany) and chromatograms were developed and quantified as described 
previously [75].  
3.4.2. Extraction and quantification of sphingolipids using mass 
spectrometry  
Sperm cells, testis, and Sertoli cells were frozen in liquid nitrogen and ground 
to a fine powder using the Precellys24 tissue homogenizer (PeqLab). Lipids were 
extracted and fractionated using solid-phase-extraction on silica columns [76]. Long 
chain bases, ceramides, and hexosylceramides were eluted with acetone/2-propanol 
(9:1, v/v) and sphingomyelin was eluted with methanol. The purified sphingolipids 
were analyzed via direct infusion nanospray mass-spectrometry using an Agilent 
6530 Accurate-Mass Q-TOF LC/MS device [76]. Sphingolipids were quantified after 
collision-induced dissociation by scanning for specific fragment ions: long chain 
bases, NL of 18. 0106; ceramides, EIC m/z 264. 2686 or m/z 262. 2493; 
hexosylceramides, EIC m/z 264.2686; sphingomyelin, 184. 0739. Internal standards 
were added for each sphingolipid class [77].  
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3.5. Identification of mGBA2 by mass spectrometry 
For LCMS, proteins of Sertoli cells, testis, and sperm were separated on SDS 
gels and stained with Coomassie. Per lane, 14-17 gel slices were excised, proteins 
were in-gel digested with trypsin (Promega), peptides were separated in a 90 or 
180 min gradient by a nanoAcquity LC System equipped with a HSS T3 analytical 
column (1.8 µm particle, 75 µm x 150 mm) (Waters), and analyzed by 
ESI-LC-MS/MS using an LTQ Orbitrap Elite mass spectrometer (Thermo Scientific). 
All database searches were performed using SEQUEST as well as MS Amanda 
(Mechtler lab, Vienna, Austria) algorithm, embedded in Proteome DiscovererTM (Rev. 
1.4, Thermo Electron© 2008-2011), with a NCBI protein database (mouse, accession 
number NP_766280.2, accessed June 13, 2013). Only fully tryptic peptides with up to 
two missed cleavages were accepted. Oxidation of methionine was permitted as 
variable modification. The mass tolerance for precursor ions was set to 10 ppm; the 
mass tolerance for fragment ions was set to 0.4 amu. To filter the results, a peptide 
FDR threshold of 0.01 (q-value) according to Percolator was set in Proteome 
Discoverer, two peptides per protein and peptides with search result rank 1 were 
required. 
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4. Results  
4.1. GBA2-specific antibodies  
 To investigate the intracellular localization of GBA2, monoclonal antibodies 
directed against four different peptide epitopes were generated (Table 1).  
 
 
 
 
 
 
 
 
 
Table 1. Monoclonal GBA2-specific antibodies. The position of the peptide epitope, the 
antibody label, and the species, in which the antibody has been generated are indicated. 
 
The peptides were chosen based on their antigenicity and position in the 
mouse GBA2 protein-sequence. In particular, epitopes located in the N and C 
terminus were chosen to reveal the subcellular localization of GBA2 and, thereby, 
solve the discrepancy in the literature about the subcellular localization of GBA2. 
Peptide 1 is located in the N terminus and peptide 4 in the C terminus. Peptide 2 is 
located in the catalytic beta-glucocerebrosidase domain, while peptide 3 is located 
downstream outside the catalytic domain (Figure 5a, 25). Furthermore, antibodies 
against peptides 2, 3, and 4 will allow to confirm the absence of GBA2 protein in 
GBA2-knockout mice.    
Peptide 
(epitope) 
Amino 
acids 
Antibody 
label 
Species 
1 36 – 50 4A12 Rat 
2 358 – 377 4D7 Rat 
3 505 – 529 2F8 Rat 
4 720 – 744 5A8 Rat 
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The specificity of the antibodies was evaluated using Western-blot analysis 
and immunocytochemistry. The monoclonal antibodies 4A12, 4D7, 2F8, and 5A8 
detected the heterologously expressed GBA2 protein in HEK293 cells at 110 kDa, 
which is also detected by the HA antibody (Figure 5b). Furthermore, the 4A12, 2F8, 
and 5A8 antibodies detected the endogenously expressed GBA2 in protein lysates 
from wild-type testis and did not show a specific band at the corresponding height in 
lysates from GBA2 knockout-testis (Figure 5b). The 4A12 antibody additionally 
recognized a band of larger molecular weight in both wild-type and GBA2 
knockout-testis (Figure 5b). Only the 4D7 antibody did not detect the endogenously 
expressed GBA2 protein, but the heterologously expressed protein in HEK293 cells. 
The specificity of the antibodies was confirmed by immunocytochemistry (Figure 5c). 
HEK293 cells were transfected with GFP-tagged GBA2 and the antibody staining 
co-localized with the GFP fluorescence. In line with the results from Western-blot 
analysis, the 4D7 antibody did not show GBA2-specific labelling (Figure 5c). 
In conclusion, the newly generated monoclonal peptide antibodies against 
GBA2 are a reliable tool to detect GBA2 using Western blot and 
immunocytochemistry [26].   
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Figure 5. GBA2-specific antibodies. (a) Schematic representation of the mouse GBA2 
protein-sequence showing the position of the different peptide epitopes (red). The region 
against which a polyclonal antibody was generated is indicated [30]. The catalytic domain 
(beta-glucocerebrosidase, green) and the region that is deleted in GBA2 knockout-mice are 
also shown. Amino-acid positions for the different regions are shown in brackets. (b) 
Western-blot analysis of total protein lysates from HEK293 wild-type (NT, control) cells, 
GBA2-HA over-expressing cells, and wild-type (+/+) and GBA2 knockout-testis (-/-). The blot 
was labeled with a HA antibody and the GBA2-specific antibodies 4A12 (top left), 4D7 (top 
right), 2F8 (bottom left), and 5A8 (bottom right). β-actin was used as a loading control.  (c) 
Immunocytochemical analysis of HEK293 cells expressing GBA2-GFP (green) labeled with 
the 4A12, 4D7, 2F8, and 5A8 (red) antibodies along with DAPI (blue) to stain the DNA. Non-
transfected HEK293 cells are shown on the right. Scale bar: 25 µm. 
 
4.2. Subcellular localization of GBA2 
To understand the function of GBA2, its subcellular localization was 
elucidated. Earlier reports proposed that GBA2 is an integral plasma-membrane 
protein with one transmembrane domain and the N terminus containing the catalytic 
domain facing the extracellular space [32]. However, GlcCer is incorporated in the 
inner leaflet of the plasma membrane [1] and would, therefore, not be accessible as a 
substrate for GBA2. To resolve this discrepancy, the subcellular localization of GBA2 
was studied using different techniques. First, it was tested whether the N terminus of 
GBA2 indeed faces the extracellular space. HEK293 cells over-expressing GBA2 
were labeled with the 4A12 antibody (against peptide 1 at the N terminus) with and 
without permeabilization of the cells by Triton X-100. As a control, cells were co-
transfected with GFP. Labelling of GBA2 was only observed when cells had been 
permeabilized, indicating that the N terminus of GBA2 does not face the extracellular 
space (Figure 6a).   
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This result was corroborated with a fluorescence protease-protection (FPP) 
assay. The assay is based on the accessibility of proteases versus their 
inaccessibility to polypeptides that are located in the lumen of organelles [71]. To 
determine the topology, the protein of interest is fused to a fluorescent protein. 
Trypsin treatment of permeabilized or non-permeabilized cells allows to determine 
the localization of the fluorescent tag relative to the membrane [71]. HEK293 cells 
expressing a N-terminally eGFP-tagged GBA2 were imaged before and after 
treatment with 4 mM trypsin (Figure 6b). As a control, HEK293 cells were transfected 
with a YFP-tagged GPI-anchored prion protein (YFP-PrP) with the YFP facing the 
extracellular space [78]. After trypsin treatment, the fluorescence of YFP-PrP was 
diminished, whereas the fluorescence in cells expressing the eGFP-tagged GBA2 
remained unchanged (Figure 6b). Thus, the N terminus of GBA2 is not accessible 
from the extracellular side.  
Experiments performed by Dr. Heinz-Gerd Körschen revealed that GBA2 is 
not a transmembrane but rather a membrane-associated protein [26]. To determine if 
GBA2 is associated with the plasma membrane, GBA2-expressing HEK293 cells 
were co-transfected with a GFP-tagged CAAX membrane anchor, which is 
incorporated into the plasma membrane via its lipid anchor. Transfected cells were 
subjected to unroofing by ultrasonification. This technique generates 
plasma-membrane sheets exposing the cytosolic side of the cell [79]. Membrane 
sheets were labeled with a GBA2-specific antibody and identified by GFP 
fluorescence (Figure 6c). However, GBA2 expression was absent in the membrane 
sheets, indicating that in HEK293 cells, GBA2 is not associated with the plasma 
membrane (Figure 6c).  
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Figure 6. GBA2 topology. (a) Non-permeabilized (left) and Triton X-100 permeabilized 
(right) HEK293 cells over-expressing GBA2 labeled with the 4A12 antibody (red). As a 
control, cells were transfected with CAAX-GFP (green). (b) HEK293 cells transfected with 
YFP-PrP (positive control; yellow; indicated by arrows) or eGFP-GBA2 (green). Cells were 
imaged before (control, left) and after treatment with 4 mM trypsin for 1 min (right). The 
YFP-PrP signals (yellow) at the membrane of control cells vanished after trypsin treatment, 
indicating proteolysis of extracellular proteins. However, the eGFP fluorescence (green) in 
GBA2-expressing HEK293 cells did not change, demonstrating that the N terminus is not 
facing the extracellular space. (c) GFP labeled-membrane sheets (green) of HEK293 cells 
over-expressing GBA2. Cells were transfected with GFP-tagged CAAX membrane anchor 
and unroofed by ultrasonification. GBA2 was detected by the 4A12 antibody (red). Scale 
bars: 25 µm. 
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To reveal where GBA2 is localized in the cell, the FPP assay was performed 
under permeabilizing conditions. Before trypsin treatment, cells were permeabilized 
with digitonin (20 µM) for 1 min, which allows trypsin to enter the cell. Thus, 
fluorescent moieties facing the cytoplasmic side will be degraded [71]. Cells were 
transfected with GBA2 with eGFP fused to either the N or C terminus and imaged 
before and after treatment with digitonin and trypsin (Figure 7a). As a control, 
HEK293 cells were co-transfected with CD3δ containing either a cytoplasmic 
C-terminal CFP-tag or a lumenal N-terminal YFP-tag [71]. After trypsin treatment, the 
YFP signal in CD3δ transfected cells remained unchanged, whereas the CFP signal 
in CD3δ transfected cells was diminished, demonstrating cytosolic protein 
degradation (Figure 7a). In eGFP-tagged GBA2-expressing HEK293 cells, the 
fluorescence was diminished for both constructs (Figure 7a). Thus, both the N and C 
terminus of GBA2 are accessible from the cytoplasmic side.     
To determine whether GBA2 is localized at specific organelles in the cell, 
co-localization studies using marker antibodies for the endoplasmic reticulum (ER), 
the Golgi, and the lysosomes were performed.  GBA2 is mainly expressed in the 
cytoplasm (Figure 7b). However, GBA2 expression also overlapped with calnexin, a 
marker for the ER, GM-130, a marker for the cis-Golgi, and giantin, a marker for the 
Golgi cisternae (Figure 7b), but not with Lamp 1, a marker for lysosomes. Since the 
localization of the over-expressed protein in HEK293 cells might differ from the 
endogenously expressed GBA2 protein, co-localization experiments were also 
performed in hippocampal neurons. GBA2 expression displayed a similar expression 
pattern in these cells, demonstrating that indeed GBA2 is localized at the ER and the 
Golgi [26]. 
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Figure 7. GBA2 is localized at the ER and Golgi with both N and C terminus facing the 
cytosol.  (a) HEK293 cells were transfected with eGFP-GBA2 or GBA2-eGFP (green). 
YFP-CD3δ (YFP facing the ER lumen; yellow) and CD3δ-CFP (CFP facing the cytosol; cyan) 
were used as controls. Cells were imaged before (left) and after treatment with 20 µm 
digitonin (middle) and 4 mM trypsin (right) for 1 min each. After trypsin treatment, the 
YFP-CD3δ signal remained unchanged, whereas the CFP-CD3δ signal decreased, indicating 
proteolysis of cytosolic proteins. However, in GBA2-expressing HEK293 cells, eGFP 
fluorescence (green) was diminished for both constructs, demonstrating that both the N and 
C terminus of GBA2 are accessible from the cytoplasmic side. Scale bar: 25 µm. (b) HEK293 
cells over-expressing GBA2 were labeled with the 4A12 (GBA2-specific; red), calnexin (ER; 
green), GM-130 (cis-Golgi; green), giantin (Golgi cisternae; green), and Lamp 1 (lysosomes; 
green) antibodies. DAPI was used to label the DNA (blue). Scale bar: 5 µm. 
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Taken together, GBA2 is a non-integral, membrane-associated protein at the 
ER and the Golgi with both the N and the C terminus facing the cytoplasm (Figure 8). 
  
 
 
 
 
 
 
 
Figure 8. Schematic representation of the topology and localization of GBA2. GBA2 
(red) is present at the ER (cyan) and the cis-Golgi (blue) with both the N and the C terminus 
facing the cytoplasm [26]. 
 
4.3. GBA2 is expressed in Sertoli cells  
GBA2 is highly expressed in the testis [30]; however, its precise localization 
within the testis is ill-defined. GBA2 has been proposed to be expressed in Sertoli 
cells [30], which are the only somatic cells in the seminiferous tubules and are 
important for spermatogenesis [43]. To investigate the expression pattern of GBA2 in 
the testis in more detail, testis cross-sections were labeled with GBA2-specific 
antibodies and an anti-tubulin III antibody, a marker for Sertoli cells [80] (Figure 9a). 
Indeed, GBA2 expression overlapped with tubulin III, demonstrating that GBA2 is 
expressed in Sertoli cells (Figure 9a). To verify this result, germ and Sertoli cells were 
isolated and the expression of GBA2 was analyzed by immunocytochemistry. Again, 
the expression pattern of GBA2 and tubulin III overlapped (Figure 9b), confirming that 
GBA2 is predominantly expressed in Sertoli cells. In adult testis, Sertoli cells only 
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account for 5-10% of the total cells [81]. However, 7 days after birth (P7), the majority 
of cells in the testis are Sertoli cells [82]. Thus, I isolated Sertoli cells at P7 and 
analyzed the expression of GBA2 by Western blot (Figure 9c). Indeed, GBA2 was 
expressed in Sertoli cells at P7. So far, there was no indication of GBA2 expression 
in germ cells. Therefore, I analyzed whether GBA2 is expressed in mature sperm. 
Labelling of mouse sperm with GBA2-specific antibodies did not reveal a specific 
staining for GBA2 (data not shown). In Western-blot analysis, a weak band at 110 
kDa was detected in total lysates from mouse sperm that was absent in lysates from 
GBA2 knockout-sperm (Figure 9d). To unequivocally reveal whether GBA2 is only 
expressed in Sertoli cells or also in sperm, mass spectrometric analysis of proteins 
from testis, Sertoli cells, and sperm was performed (Figure 24 in appendix).  Unique 
peptides for GBA2 were only identified in testis and Sertoli cells, but not in sperm, 
demonstrating that GBA2 is only expressed in Sertoli cells.  
 
Results 
 
36 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
37 | P a g e  
 
Figure 9. GBA2 is expressed in Sertoli cells. (a) Testis cross-sections were labeled with 
the polyclonal anti-GBA2 antibody (red) and an anti-tubulin III antibody (green). DAPI was 
(blue) used as a DNA marker to label the nuclei. Top: wild-type, +/+; bottom: GBA2 knockout, 
-/-. Scale bar: 50 µm. (b) See (a) for isolated and labeled germ and Sertoli cells. Scale bar: 
100 µm. (c) Western-blot analysis using total protein lysates from P7 Sertoli cells. The blot 
has been labeled with the GBA2-specific 2F8 antibody; beta-tubulin has been used as a 
loading control. Wild-type: +/+, GBA2 knockout: -/-, HEK293 cells expressing GBA2-HA: 
GBA2-HA. (d) See (c) for mature sperm. 
4.4. GBA2 expression during sperm development  
To unravel the function of GBA2 during spermatogenesis, its expression and 
enzymatic activity was analyzed during the first spermatogenic wave. Only the first 
wave is synchronized and allows correlating protein expression and activity with 
specific stages during sperm development. In the adult testis, spermatogenic waves 
are no longer synchronized, making it difficult to investigate protein function at a 
particular developmental stage. I focused on two different time points in the first 
wave: pre-puberty (P7) and early puberty (P21), and compared them to adult animals 
(≥ 25 weeks old).  
During the first spermatogenic wave, GBA2 followed the expression pattern of 
the Sertoli cell marker tubulin III (Figure 10a). Normalizing GBA2 expression to the 
expression level of tubulin III using Western-blot analysis revealed that GBA2 
expression increased from P7 to P21 and decreased in the adult state (Figure 10b, 
c). Similarly, GBA2 activity increased from P7 to P21 and decreased from P21 to 
adult (Figure 10d) (enzyme activity measurements were performed by Sophie 
Schonauer, caesar). These results suggest that GBA2 function is particularly 
important at the onset of puberty in the first spermatogenic wave. 
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Figure 10. GBA2 expression and activity during the first spermatogenic wave. 
(a) Testis cross-sections from P7 (top), P21 (middle), and adult (bottom) testis were labeled 
with the polyclonal anti-GBA2 (red), and the tubulin III (green) antibody. DAPI (blue) was 
used to visualize DNA. Scale bar: 50 µm. (b) Western-blot analysis using total protein lysates 
from P7, P21, and adult testis. Protein lysates of HEK293 cells expressing GBA2-HA (HA) 
were used as a positive control. The blot has been labeled with the GBA2-specific 2F8 
antibody and tubulin III (TubIII) as a marker for Sertoli cells. Calnexin (Cal) served as a 
loading control. Protein lysates from wild-type (+/+) and GBA2 knockout-brain (-/-) have been 
used as controls. (c) Quantification of GBA2 protein expression. GBA2 expression levels 
have been normalized to the expression level of tubulin III. (d) Fluorescence-based 
beta-glucosidase activity measured at pH 6 in protein lysates from P7, P21, and adult 
wild-type testes. Data are presented as mean ± S.D.; n numbers and p values determined 
using One-way ANOVA are indicated.  
 
4.5. Lack of GBA2 leads to accumulation of GlcCer in testis and 
sperm  
Sertoli cells and germ cells contain a different repertoire of glycosphingolipids. 
While Sertoli cells mainly contain sphingolipids with saturated long-chain fatty 
acids (≥C18), germ cells show a stage-specific increase in neutral fucosylated 
glycosphingolipids during spermatogenesis [83] [84] [85]. Developing germ cells have 
been shown to contain very long-chain (C28, C30, and C32) polyunsaturated fatty 
acids [86]. Also associated with differentiating germ cells are ceramides, 
sphingomyelins, and gangliosides [85]. We set out to determine, which 
glycosphingolipids accumulate in the different cell types during spermatogenesis.  
Quantitative analysis of sphingolipid content in adult testis, P7 Sertoli cells, 
and sperm was performed using mass spectrometry (in collaboration with the group 
of Prof. Peter Dörmann, Molecular Biotechnology, University of Bonn). In detail, we 
determined the total mass of long chain bases (LCB; C18), saturated and unsaturated 
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ceramides (Cer; C16 – C26), hexocylceramides (HexCer; C14 – C24; both GlcCer and 
galactosylceramide (GalCer)), and sphingomyelin (SM; C14 – C26). In GBA2 
knockout-testis, LCB, Cer, and SM levels did not change, whereas HexCer levels 
were dramatically increased (Figure 11a). Similarly, GBA2 knockout-sperm showed 
an increase in HexCer levels, but levels of LCB, Cer, and SM remained unchanged 
(Figure 11b). In both GBA2 knockout-testis and sperm, levels of saturated C16, C18, 
C22, and C24 HexCer were increased. However, the levels of C28 HexCer were 
elevated only in GBA2 knockout-testis, but not in GBA2 knockout-sperm 
(Figure 11d, e). Since it is not possible to distinguish between GlcCer and GalCer 
using mass spectrometry, we performed thin-layer chromatography (TLC). GalCer 
levels did not change in GBA2 knockout-testis (data not shown), indicating that the 
changes observed in the HexCer levels represent changes in GlcCer levels. In P7 
Sertoli cells, no change in any of the lipids was observed between wild-type and 
GBA2 knockout-mice (Figure 11c). 
Thus, in the absence of GBA2, a plethora of GlcCer species with different 
chain lengths accumulate in testis and sperm, but not in P7 Sertoli cells. In adult 
testis, it is not possible to quantitatively separate Sertoli cells from germ cells, which 
makes it difficult to analyze glycosphingolipid levels exclusively in Sertoli cells. 
However, increased levels of saturated long chain GlcCer (C28) in GBA2 knockout-
testis, but not sperm, might indicate accumulation of GlcCer in adult Sertoli cells, 
which predominantly contain saturated long-chain sphingolipids. These results 
demonstrate that the lack of GBA2 also alters the levels of GlcCer in germ cells and 
sperm, although GBA2 is not expressed in these cell types, at least not in detectable 
amounts.  
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Figure 11. Quantitative analysis of lipid content. (a) Quantitative mass spectrometric analysis of long-chain bases (LCB), 
ceramides (Cer), hexosylceramides (HexCer), and sphingomyelin (SM) in wild-type (+/+) and GBA2 knockout (-/-) testis. (b) See 
(a) for sperm. (c) See (a) for P7 Sertoli cells. (d) Quantitative lipid profiles of HexCer with different chain lengths from wild-type 
(+/+) and GBA2 knockout-testis (-/-). (e) See (d) for sperm. Data are presented as mean ± S.D.; n numbers and p values 
determined using One-way ANOVA are indicated. 
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4.6. Loss of GBA2 causes cytoskeletal defects in testis  
Sperm from GBA2 knockout-mice display globozoospermia [30]. However, the 
molecular mechanism underlying this defect is not known. Shaping of the sperm 
head depends on cytoskeletal rearrangements in Sertoli cells and developing 
spermatids [64]. To investigate whether defects in the cytoskeleton underlie defects 
in sperm-head formation, I analyzed the actin and tubulin cytoskeleton in wild-type 
and GBA2 knockout-testis using fluorescently-tagged phalloidin and an anti-tubulin 
antibody (Figure 12a). While the organization of actin bundles around the sperm 
heads in wild-type testis followed a clear sickle shape, the F-actin labeling in GBA2 
knockout-testis appeared augmented and the actin bundles around sperm heads 
were severely disorganized (Figure 12a).  
To determine the cellular origin of this defect, germ and Sertoli cells were 
isolated from adult wild-type and GBA2 knockout-testis. To distinguish between 
Sertoli cells and germ cells, the Sertoli cell-specific marker tubulin III was used. 
Immunocytochemistry revealed that both the actin and tubulin network was more 
extensive in Sertoli cells from GBA2 knockout-testis (Figure 12b).  
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Figure 12. Cytoskeletal defects in adult GBA2 knockout-testis. (a) Testis cross-sections 
of adult wild-type (+/+) and GBA2 knockout-mice (-/-) labeled with a beta-tubulin antibody 
(red), phalloidin (green) to visualize F-actin, and DAPI (blue) to label the DNA. The ES is 
indicated by arrows. Scale bars: overview: 50 µm, zoom-in: 10 µm. (b) Germ and Sertoli cells 
isolated from wild-type (+/+) and GBA2 knockout-mice (-/-) labeled with an anti-tubulin III 
(red) antibody, phalloidin (green), and DAPI (blue). Scale bars: overview: 50 µm, zoom-in: 
10 µm. 
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4.7. Cytoskeletal defects develop in the first spermatogenic wave 
According to its expression and activity, GBA2 is particularly important during 
the first spermatogenic wave (Figure 10). Thus, I analyzed whether the cytoskeletal 
defects already develop in the first spermatogenic wave. To compare the first 
spermatogenic wave between wild-type and GBA2 knockout-mice, four different time 
points were analyzed: P7, P21, P23, and P34 (Figure 13).   
Immunohistochemical analysis of F-actin and microtubules in testis 
cross-sections did not show a difference between wild-type and GBA2 knockout-
testis at P7 (P7, Figure 13). At P21, in wild-type testis, F-actin was mainly present at 
the blood-testis barrier and at the junctions between Sertoli cells and germ cells 
(P21, Figure 13). However, in GBA2 knockout-testis, only the F-actin structures lining 
the blood-testis barrier were formed, but those around the junctions appeared 
disturbed (P21, Figure 13). This defect was even more pronounced at P23 (P23, 
Figure 13). At P34, in wild-type testis, F-actin forms the ectoplasmic specialization 
(ES) embracing the sickle-shaped sperm heads. However, in GBA2 knockout-testis, 
distinct F-actin-based structures surrounding the sperm heads were absent and the 
sperm heads appeared deformed (P34, Figure 13).  
These results show that during the first spermatogenic wave, defects in the 
actin cytoskeleton first appear at P21, which correlates with the peak in GBA2 
expression and activity around puberty (Figure 10c, d). 
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Figure 13. Analysis of cytoskeletal defects in the first wave of spermatogenesis. Testis 
cross-sections from P7, P21, P23, and P34 wild-type (+/+) and GBA2 knockout-mice (-/-) 
stained with phalloidin to visualize F-actin (green), a beta-tubulin antibody (red), and DAPI to 
label the DNA (blue). F-actin at the blood-testis barrier, junctions between Sertoli-Sertoli and 
Sertoli-germ cells, and the ectoplasmic specialization (ES) are indicated by arrows. Scale 
bar: overview: 50 µm; zoom-in: 20 µm. 
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4.8. GBA2 knockout-spermatids contain longer microtubule 
manchettes  
Immunohistochemical analysis of individual spermatid microtubule structures 
in testis-sections is difficult, because the developing sperm are tightly packed within 
seminiferous tubules (Figure 13). To analyze microtubule structures in more detail, 
germ cells were isolated and microtubules were immunocytochemically analyzed 
(Figure 14b). During spermatid elongation, the microtubule cytoskeleton forms a 
manchette around the neck of the sperm head just below the acrosome [56] [64]. 
Movement of the manchette towards the flagellum generates forces sufficient to 
shape the post-acrosomal region of the sperm head (Figure 14a) [58] [59]. Thus, I 
compared the development of the manchette in wild-type and GBA2 knockout-mice 
(Figure 14b). Wild-type spermatids developed a symmetric, conical-shaped 
manchette that regressed with the progression of spermatogenesis (Figure 14b). 
However, in GBA2-knockout spermatids, microtubules of the manchette persisted 
and did not regress even at stage XIV of spermatogenesis (Figure 14b). When the 
length of the microtubule manchettes between stages IX – XIV of spermatogenesis 
was measured, GBA2-knockout spermatids displayed significantly longer manchettes 
than wild-type spermatids (wild-type: 5.2 ± 0.6 µm vs. GBA2 knockout: 11.2 ± 0.9 µm; 
Figure 14c).  Thus, accumulation of GlcCer in the absence of GBA2 seems to affect 
the actin cytoskeleton in Sertoli cells and the microtubule cytoskeleton in germ cells.  
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Figure 14. Development of the sperm manchette in wild-type and GBA2 
knockout-mice. (a) The manchette consists of a perinuclear ring attached to several vertical 
microtubules (red) around the spermatid head (blue). The downward motion of the 
manchette is responsible for shaping the post-acrosomal region of the sperm head [59]. A 
schematic representation of the sperm manchette is shown for stages IX to XIV of 
spermatogenesis. (b) Germ cells isolated from wild-type (+/+) and GBA2 knockout-mice (-/-) 
were stained with an anti-beta tubulin antibody (red) and DAPI to label the DNA (blue). 
Stages VIII, IX, XI-XII, and XIV of spermatogenesis are shown. Scale bars are indicated. (c) 
Mean length of microtubule manchettes measured in wild-type (+/+) and GBA2 
knockout-spermatids (-/-). Data is presented as mean ± S.D.; n numbers and the p value 
determined using One-way ANOVA is indicated.  
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4.9. A defect in acrosome formation during the first spermatogenic 
wave results in globozoospermia in GBA2 knockout-mice  
Globozoospermia is the main phenotypic defect in GBA2 knockout-mice [30]. 
The hallmark of globozoospermia is a malformed acrosome [45]. To test whether 
sperm of the first spermatogenic wave from GBA2 knockout-mice already display a 
defect in acrosome formation, I analyzed sperm from wild-type and GBA2 knockout-
mice at P34 using immunocytochemistry. Indeed, GBA2 knockout-sperm showed a 
severely deformed acrosome (Figure 15a).  
To test whether the defect in acrosome formation develops due to the 
cytoskeletal, I analyzed acrosome formation in wild-type and GBA2 knockout-mice 
during the first spermatogenic wave (Figure 15c). Acrosome formation is 
characterized by three major phases: the Golgi phase, the cap phase, and the 
acrosome phase (Figure 15b).  
I followed acrosome formation immunohistochemically using 
fluorescently-tagged lectin from peanut. Peanut lectin binds carbohydrate moieties on 
the outer membrane of the acrosome [87]. In the Golgi phase of wild-type testis, 
proacrosomal vesicles had already fused to form the acrosomal vesicle. However, in 
GBA2 knockout-testis, proacrosomal vesicles remained dispersed (P21, Figure 15c). 
Furthermore, in the cap phase of wild-type testis, the acrosomal vesicle formed a 
cap-like structure around the nucleus. However, in GBA2 knockout-testis, formation 
of the cap-like structure was incomplete (P23, Figure 15c). Finally, in the acrosome 
phase, well defined, sickle-shaped acrosomes were formed around the spermatid 
heads in wild-type testis, whereas in GBA2 knockout-testis, many spermatids lacked 
an acrosome and only a few contained acrosome-like structures (P34, Figure 15c). 
Thus, the defects in acrosome formation and the cytoskeleton in GBA2 
knockout-mice are evident at the same time-point during the first spermatogenic 
wave and correlate with the peak in GBA2 expression and activity in wild-type mice.  
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Figure 15. Acrosome formation. (a) P34 Wild-type (+/+) and GBA2 knockout-sperm (-/-) 
isolated from P34 mice labeled with FITC tagged-peanut lectin (green) to visualize the 
acrosome, mitotracker (red) to label the mitochondria, and DAPI (blue) to label the DNA. 
Scale bar: 20 µm. (b) At P21, in the Golgi phase, vesicles from the trans-Golgi network fuse 
at one pole of the nucleus (blue) to form a single large vesicle that attaches to the nucleus. 
At P23, in the cap phase, the acrosomal vesicle flattens over the nuclear membrane, forming 
a semi-circular cap-like structure around the spermatid head. At P34, in the acrosome phase, 
the cap-like structure stretches over the spermatid [47] [88]. (c) Testis cross-sections from 
P21, P23, and P34 wild-type (+/+) and GBA2 knockout-mice (-/-) labeled with peanut-lectin to 
label the acrosome (green), an anti-beta tubulin antibody (red), and DAPI to visualize DNA 
(blue). Scale bar: overview: 50 µm; zoom-in: 20 µm.  
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In summary, accumulation of GlcCer in Sertoli and germ cells in the absence 
of GBA2 disturbs cytoskeletal structures during sperm development. In turn, this 
seems to impair acrosome and sperm-head formation resulting in globozoospermia.   
 
4.10. Dermal fibroblasts as a model system 
Next, I wanted to investigate the molecular mechanisms underlying the 
cytoskeletal defects during accumulation of GlcCer. However, isolated germ and 
Sertoli cells are difficult to culture and manipulate, rendering a detailed analysis of 
cytoskeletal dynamics difficult. However, GBA2 is also expressed in the skin [30], and 
dermal fibroblasts from adult mice are easy to maintain and manipulate in culture. 
Therefore, I tested whether dermal fibroblasts could be used as a model system to 
study cytoskeletal dynamics.  
Western-blot analysis of protein lysates from wild-type fibroblasts showed a 
GBA2-specific band, which was absent in protein lysates from GBA2 
knockout-fibroblasts, demonstrating that GBA2 is expressed in dermal fibroblasts 
(Figure 16a). Using thin layer chromatography (TLC) (conducted by Sophie 
Schonauer, caesar), we could demonstrate that GlcCer accumulated in GBA2 
knockout-fibroblasts (Figure 16b, c). Most importantly, GBA2 knockout-fibroblasts 
also displayed cytoskeletal defects: organization of the microtubule and actin 
cytoskeleton was dramatically altered, resulting in a change in morphology compared 
to wild-type fibroblasts (Figure 16d). Thus, dermal fibroblasts from adult mice qualify 
as a good model system to study the effects of GlcCer accumulation on cytoskeletal 
dynamics. 
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Figure 16. Mouse dermal fibroblasts as a model system. (a) Western-blot analysis of 
wild-type (+/+) and GBA2 knockout-fibroblasts (-/-). The blot was probed with the 
GBA2-specific 2F8 antibody. Protein lysates from HEK293 cells expressing GBA2-HA (HA) 
were used as a positive control and calnexin (Cal) served as a loading control. (b) Thin layer 
chromatograph of wild-type (+/+) and GBA2 knockout-fibroblasts (-/-). Levels of 
glucosylceramide (GlcCer), lactosylceramide (LacCer), and sphingomyelin (SM) have been 
analyzed. (c) Left: quantification of GlcCer in wild-type (+/+) and GBA2 
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knockout-fibroblasts (-/-). Right: relative change in GlcCer levels in GBA2 knockout 
compared to wild-type fibroblasts (indicated by the dotted line). (d) Fluorescent labeling of 
the cytoskeleton in dermal fibroblasts isolated from wild-type (+/+) and GBA2 knockout-mice 
(-/-). Cells were transfected with lifeact-GFP (green) to label actin and EB3-mcherry (red) to 
label the plus-tips of microtubules. Scale bar: 20 µm. All data are presented as mean ± S.D.; 
n numbers and p values calculated using One-way ANOVA are indicated. 
4.11. GlcCer accumulation in the absence of GBA2 affects actin 
dynamics 
To analyze how accumulation of GlcCer in the absence of GBA2 affects 
cytoskeletal dynamics, I first analyzed the actin dynamics. Since dermal fibroblasts in 
culture are morphologically heterogeneous, comparative analysis of their 
cytoskeleton is difficult. Therefore, wild-type and GBA2 knockout-fibroblasts were 
forced to acquire a specific morphology by seeding them onto glass-slides with 
fibronectin-coated micro-patterns. Four different shapes of micro-patterns were used: 
disc, cross-bow, dumb-bell, and Y (Figure 17a).  
Immunofluorescent labelling of F-actin revealed dramatic differences: the 
F-actin network in GBA2 knockout-fibroblasts was more extensive and showed 
protruding F-actin structures (filopodia and lamellipodia) at the periphery. This effect 
was more pronounced on the cross-bow and disc micro-patterns (Figure 17a).  
Quantification of filopodia and lamellipodia revealed that GBA2 knockout-fibroblasts 
contain more filopodia and lamellipodia per cell compared to the wild-type fibroblasts. 
While wild-type fibroblasts contained 0.99 ± 0.3 filopodia and 1.76 ± 0.41 lamellipodia 
per cell, GBA2 knockout-fibroblasts contained 1.62 ± 0.47 filopodia and 3.08 ± 0.20 
lamellipodia per cell (Figure 17b). 
The formation of filopodia and lamellipodia depends upon actin 
polymerization [89] [90]. Therefore, the turnover rate of G-actin to F-actin in wild-type 
and GBA2 knockout-fibroblasts was determined as a measure of actin 
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polymerization. The ratio of F-actin to G-actin was higher in GBA2 
knockout-fibroblasts (Figure 17c), indicating that an increase in actin polymerization 
underlies the increase in filopodia and lamellipodia formation. In principle, this assay 
can be applied to every cell type or tissue. Thus, I tested whether a difference in actin 
polymerization also underlies the cytoskeletal defects observed in GBA2 
knockout-testis. However, the ratio of G-actin to F-actin was not different between 
wild-type and GBA2 knockout-testis, which could be due to the cellular heterogeneity 
in testis (Figure 17d).     
Members of the Rho family of GTPases have been shown to be crucial for 
controlling actin dynamics. Cdc-42 and Rac1 regulate the formation of filopodia and 
lamellipodia, respectively [91] [92] [93] [94].  To investigate if a change in the 
expression level of Cdc42 or Rac1 underlies the increase in filopodia and 
lamellipodia formation observed in GBA2 knockout-fibroblasts, I first determined their 
mRNA expression levels using quantitative real-time PCR. The mRNA levels for both 
Cdc-42 and Rac1 were increased in GBA2 knockout compared to wild-type 
fibroblasts (Cdc-42: 1.24 ± 0.15; Rac1: 1.22 ± 0.11) (Figure 17e).  However, this 
change was not translated to a change in protein expression - Cdc-42 and Rac1 
protein expression-levels were similar between wild-type and GBA2 
knockout-fibroblasts (Figure 17g, h). Hence, a change in protein expression of the 
key regulators, the Rho GTPases Cdc-42 and Rac1, does not seem to underlie the 
increase in filopodia and lamellipodia formation in GBA2 knockout-fibroblasts. 
In testis, Rho GTPases regulate the cytoskeletal dynamics at the ectoplasmic 
specialization [95]. In GBA2 knockout-mice, formation of the apical ectoplasmic 
specialization is impaired (Figure 12a). Thus, I also analyzed mRNA expression 
levels of Cdc-42 and Rac1 in testis. However, no change in the expression of Cdc-42 
and Rac1 was observed in GBA2 knockout compared to wild-type mice (Figure 17f). 
Nectin 2 has also been shown to control actin dynamics at the ectoplasmic 
specialization [70]. However, its mRNA expression level was also not different 
between wild-type and GBA2 knockout-testis (Figure 17f). Thus, changes in 
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expression of Cdc-42, Rac1 or nectin 2 do not seem to underlie the defects in the 
actin cytoskeleton of GBA2 knockout-testis.  
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Figure 17. Analysis of the molecular mechanism underlying the defects in the actin 
cytoskeleton in GBA2 knockout-mice. (a) Immunofluorescent labeling of F-actin using 
phalloidin (green) in wild-type (+/+) and GBA2 knockout-fibroblasts (-/-) seeded on disc, 
crossbow, dumb-bell, and Y-shaped micropatterns coated with fluorescently-labeled 
fibronectin (purple). The DNA has been labeled using DAPI (blue). Scale bar: 20 µm. (b) 
Average numbers of filopodia and lamellipodia per cell in wild-type (+/+) and GBA2 knockout-
fibroblasts (-/-). (c) Quantification of G-actin to F-actin turnover in wild-type (+/+) and GBA2 
knockout-fibroblasts (-/-) by Western-blot analysis. (d) See (c) for testis. (e) mRNA 
expression levels of Cdc-42 and Rac1 in GBA2 knockout-fibroblasts relative to wild-type 
fibroblasts (indicated by black dotted line). (f) mRNA expression levels of Cdc-42, Rac1, and 
Nectin 2 in GBA2 knockout-testis relative to wild-type testis (indicated by black dotted line). 
(g) Protein expression-levels of Cdc-42 and Rac1 in wild-type (+/+) and GBA2 
knockout-fibroblasts (-/-) using Western-blot analysis. Calnexin (Cal) was used as a loading 
control. (h) Quantification of protein expression-levels of Cdc-42 and Rac1 in GBA2 
knockout-fibroblasts relative to wild-type fibroblasts (indicated by black dotted line). All data 
are represented as mean ± S.D. ‘n’ numbers and p values determined using One-way 
ANOVA are indicated. 
 
4.12. GlcCer accumulation in the absence of GBA2 affects 
microtubule dynamics 
Since microtubules in the sperm manchette of GBA2 knockout-mice persisted 
longer than in wild-type mice (Figure 18b, c), the microtubule dynamics of wild-type 
and GBA2 knockout-fibroblasts were studied in greater detail using live-cell imaging. 
To visualize growing microtubules, fibroblasts were transfected with a 
fluorescently-tagged EB3 probe. EB3 binds to the plus-ends of growing microtubules, 
which allows to determine the growth rate and persistence of microtubules using the 
Metamorph image-analysis software [96] (Figure 18a). While the microtubule 
growth-rate was similar between wild-type and GBA2 knockout-fibroblasts 
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(+/+: 16.4 ± 6.3 µm/min; -/-: 19.7 ± 6.9 µm/min), microtubule persistence in GBA2 
knockout-fibroblasts was increased (+/+: 13.3 ± 5.6 µm; -/-: 16.1 ± 6.9 µm) 
(Figure 18b, c). These results indicate that accumulation of GlcCer in the absence of 
GBA2 prolongs the persistence of microtubules in dermal fibroblasts.  
 
 
Figure 18. Microtubule dynamics in GBA2 knockout-fibroblasts. (a) Expression of 
mcherry-tagged EB3 (red) in wild-type (+/+) and GBA2 knockout-fibroblasts (-/-). EB3 labels 
the plus-tips of growing microtubules. Representative microtubule tracks (red) that were used 
to quantify microtubule dynamics are marked. Scale bar: 30 µm (b) Quantification of 
microtubule growth rate in wild-type (+/+) and GBA2 knockout-fibroblasts (-/-). Per genotype, 
3 animals were used and at least 7 cells per animal were analyzed. (c) See (b) for 
microtubule persistence. All data are represented as mean ± S.D. n numbers and p values 
determined using One-way ANOVA are indicated. 
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4.13. GlcCer accumulation augments lipid stacking in the 
plasma membrane 
 Glycosphingolipids in the membrane are organized in microdomains that 
possess specialized signaling functions [97] [98]. GlcCer is incorporated into the 
inner leaflet of the plasma membrane [99]. I hypothesized that in the absence of 
GBA2, accumulation of GlcCer alters the stacking of lipids in the plasma membrane, 
thereby affecting the function of proteins that control cytoskeletal dynamics. To 
analyze lipid stacking, giant plasma-membrane vesicles (GPMV) were isolated from 
wild-type and GBA2 knockout-fibroblasts and the phase separation was 
spectrophotometrically measured using Laurdan. Laurdan is a fluorescent membrane 
dye that displays spectral sensitivity to solvent relaxation effects [100]. A red shift in 
the emission spectrum occurs when the membrane has a liquid-crystalline 
(disordered) phase, whereas the emission is shifted to the blue range when the 
membrane has a gel-like (ordered) phase (Figure 19a) [101]. GPMVs isolated from 
wild-type fibroblasts displayed a laurdan emission peak at 460 nm, whereas GPMVs 
from GBA2 knockout-fibroblasts showed an emission peak around 440 nm 
(Figure 19b). Changes in the emission spectrum can be quantified by the generalized 
polarization (GP) index [102]. The GP value for GBA2 knockout-fibroblasts was 
significantly higher than for wild-type fibroblasts (+/+: 0.12 ± 0.03; -/-: 0.24 ± 0.03; 
Figure 19c). These observations demonstrate that the accumulation of GlcCer in 
GBA2 knockout-fibroblasts results in a highly ordered lipid stacking in the plasma 
membrane. This, in turn, could affect the function of proteins in the plasma 
membrane, e.g. of proteins that control cytoskeletal dynamics.   
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Figure 19. GlcCer accumulation leads to a highly ordered lipid stacking in the plasma 
membrane. (a) Schematic representation of the fluorescence properties of Laurdan. The dye 
is excited at 350 nm (indicated by the green line), and emission peaks at around 450 nm 
(blue), when residing in the ordered phospholipid phase and shifts to around 500 nm (red) 
when the dye resides in a more disordered phospholipid phase [103]. (b) Representative 
emission spectra of Laurdan measured in GPMVs isolated from wild-type (+/+; green) and 
GBA2 knockout-fibroblasts (-/-; purple). (c) Generalized polarization index calculated from 
Laurdan measurements presented in (b); wild-type: +/+; green, GBA2 
knockout-fibroblasts: -/-; purple. Individual data points are represented along with the 
mean ± S.D.; n numbers and p value determined by One-way ANOVA are also indicated. 
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4.14. GlcCer accumulation in the absence of GBA2 alters cellular 
behavior  
Changes in the cytoskeleton affect cellular physiology. GlcCer has been 
proposed to induce proliferation [104].  Thus, I analyzed the proliferation rate of 
fibroblasts using bromodeoxyuridine (BrdU). BrdU is a thymidine analogue, which is 
incorporated into newly synthesized DNA strands of proliferating cells [105]. 
Fibroblasts were labeled with an anti-BrdU antibody and the rate of proliferation was 
determined by calculating the ratio of proliferating cells over the total number of cells 
(Figure 20a). The rate of BrdU incorporation was not significantly different between 
wild-type and GBA2 knockout-fibroblasts, indicating that increased GlcCer levels in 
GBA2 knockout-fibroblasts do not alter cellular proliferation (Figure 20b). 
GBA2 knockout-fibroblasts display a higher number of lamellipodia 
(Figure 17b). Lamellipodia formation is a hallmark of migrating cells [106]. Thus, I 
analyzed cell migration of wild-type and GBA2 knockout-fibroblasts using a simple 
wound-healing assay (Figure 20c) [107]. The assay revealed that GBA2 
knockout-cells migrated faster than wild-type fibroblasts, especially between 2-4 
hours after starting the assay (Figure 20d).     
These results indicate that the accumulation of GlcCer in the absence of 
GBA2 changes cellular cytoskeletal dynamics, and, thereby, cell behavior, as shown 
by an increase in cell migration. 
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Figure 20. Analysis of cell proliferation and migration. (a) Wild-type (+/+) and GBA2 
knockout-fibroblasts (-/-) were treated with BrdU for 8 hours and were labeled with an 
anti-BrdU antibody (red). Scale bar: 200 µm. (b) Quantification of cellular proliferation 
determined by the rate of BrdU incorporation. The proliferation rate has been normalized to 
wild-type (indicated by black dotted line). (c) Representative images of wild-type (+/+) and 
GBA2 knockout-fibroblasts (-/-) in the wound-healing assay. (d) Quantification of migration 
rates of wild-type (+/+) and GBA2 knockout-fibroblasts (-/-) at the indicated time points. All 
data are represented as mean ± S.D. n numbers and p values determined using One-way 
ANOVA are indicated. 
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4.15. NB-DNJ-mediated inhibition of GBA2 activity induces a similar 
cellular phenotype as observed in GBA2 knockout-fibroblasts 
To verify whether the cellular defects observed in GBA2 knockout-fibroblasts 
are solely due to the loss of GBA2 and the consequent accumulation of GlcCer, the 
contribution of GBA2 in controlling cytoskeletal dynamics was independently 
assessed using N-butyldeoxynojirimycin (NB-DNJ), a blocker for GBA2 [108]. 
Wild-type fibroblasts were treated with 2 µM NB-DNJ for 48 hours. Analysis of the 
enzyme activity showed that this treatment completely inhibited GBA2 activity, while 
the activity of GBA1 remained unchanged (Figure 21a). TLC analysis revealed that 
NB-DNJ treatment resulted in the accumulation of GlcCer (Figure 21a, b; 
experiments performed by Sophie Schonauer, caesar). Immunofluorescent labeling 
of the actin cytoskeleton demonstrated that the treated cells, similar to GBA2 
knockout-fibroblasts, contained more actin protrusions compared to untreated 
wild-type cells (Figure 21c). Furthermore, NB-DNJ-treated fibroblasts also migrated 
faster than the untreated cells (Figure 21d). To determine if the NB-DNJ treatment 
also altered the plasma membrane stacking, Laurdan spectra were measured and 
GP values were calculated from GPMVs isolated from control and NB-DNJ-treated 
wild-type cells. The shift in the Laurdan spectrum of treated cells was similar to the 
shift in GBA2 knockout-fibroblasts. While the GP value for the untreated controls was 
0.15 ± 0.06, the treated wild-type cells displayed a GP value of 0.26 ± 0.07 
(Figure 21e). 
These results demonstrate that inhibition of GBA2 activity by NB-DNJ results 
in a similar cellular phenotype as observed in GBA2 knockout-fibroblasts. This 
emphasizes my earlier finding that loss of GBA2 leading to accumulation of GlcCer 
alters cytoskeletal dynamics in fibroblasts.  
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Figure 21. NB-DNJ treated wild-type fibroblasts display a GBA2 knockout-phenotype. 
(a) Beta-glucocerebrosidase activity of GBA1 (pH 4.0) and GBA2 (pH 6.0) in wild-type 
fibroblasts treated with 2 µM NB-DNJ for 48 hours and untreated control cells. (b) Left: 
thin-layer chromatograph of wild-type fibroblasts treated with 2 µM NB-DNJ (+) and the 
corresponding untreated controls (-). Levels of sphingomyelin (SM), lactosylceramide 
(LacCer), and glucosylceramide (GlcCer) have been analyzed. Right: quantification of 
GlcCer from left. (c) Immunofluorescent labeling of F-actin (phalloidin, green) and DNA 
(DAPI, blue) in untreated and NB-DNJ-treated (2 µM) wild-type fibroblasts. Scale bar: 5 µm. 
(d) Quantification of migration rates of NB-DNJ-treated wild-type fibroblasts (2 µM; NB-DNJ) 
and untreated controls (+/+) at different time points in wound-healing assay. (e) Generalized 
polarization index calculated from laurdan emission spectra of wild-type fibroblasts treated 
with 2 µM NB-DNJ for 48 hours: + NB-DNJ, untreated control fibroblasts: - NB-DNJ. 
Individual data points are represented along with the mean ± S.D.; ‘n’ numbers and p values 
determined by One-way ANOVA are indicated.  
 
In summary, my results demonstrate that GBA2 is expressed in Sertoli cells. In 
the absence of GBA2, GlcCer accumulates in Sertoli cells, germ cells, and sperm. 
This alters the cytoskeletal dynamics of F-actin at the apical ES in Sertoli cells and 
the microtubule manchette in spermatids. Furthermore, using dermal fibroblasts as a 
model system, my results provide a mechanistic insight into how accumulation of 
non-lysosomal GlcCer in the absence of GBA2 affects cytoskeletal dynamics. 
Accumulation of GlcCer leads to a highly ordered lipid packaging in the plasma 
membrane, which could influence protein function in the plasma membrane. In 
particular, proteins controlling cytoskeletal dynamics seem to be sensitive to this 
change in the lipid environment, resulting in a defect in the actin and microtubule 
cytoskeleton. This could also feed-back on vesicle fusion in developing germ cells, 
leading to deformed acrosomes responsible for globozoospermia in GBA2 
knockout-mice.  
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5. Discussion  
My work demonstrates that in the absence of GBA2, GlcCer accumulates 
leading to a highly ordered lipid stacking in the plasma membrane. This in turn seems 
to affect the function of membrane proteins that regulate cytoskeletal dynamics. This 
effect is most prominent in the testis of GBA2 knockout-mice, where the cytoskeletal 
structures that shape the sperm head are disturbed causing globozoospermia and, 
thereby, a defect in fertility.  
 
5.1. Implications of the subcellular localization of GBA2 and GlcCer 
To understand the physiological function of GBA2, it is important to analyze its 
subcellular localization. Our results demonstrate that GBA2 is not a transmembrane 
protein, but rather associated with the Golgi and the ER membrane from the cytosolic 
side [26]. What is the impact of this localization for GBA2 function? GlcCer is 
synthesized at the cytosolic side of the cis-Golgi and transported to the Golgi lumen 
and ER by GLTP/FAPP2 [8] [9]. Within the Golgi lumen, GlcCer is converted to 
LacCer and consequently to higher order glycosphingolipids [8]. The localization of 
GBA2 at the cytosolic side of the Golgi implies that GlcCer is degraded close to 
where it is synthesized. Hence, GBA2 could function as a fine tuner to regulate the 
level of GlcCer that is available for higher order glycosphingolipid synthesis.  
An interesting observation is that in both GBA2 knockout-mice and mice 
treated with NB-DNJ the levels of sphingomyelin, LacCer, and higher order 
glycosphingolipids were not altered – only GlcCer levels were increased [30] [109]. 
Moreover, our lipid analyses underlined these results and revealed that also the 
levels of ceramide in GBA2 knockout-mice remained unchanged. Thus, an increase 
in GlcCer level does not change the levels of other glycosphingolipids or ceramide 
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although GlcCer serves as one of the main building blocks for higher order 
glycosphingolipids. These results suggest that lipid synthesis remains constant 
independent of the substrate availability. However, it could also mean that GlcCer, 
when it is accumulating, is not transported to the side of glycosphingolipid synthesis. 
Therefore, it is important to analyze where GlcCer accumulates in the cell. Does it 
accumulate at the place of degradation or is it transported to the plasma membrane 
and accumulate there? My results indicate that GlcCer accumulation in GBA2 
knockout-cells causes a more ordered lipid stacking in the plasma membrane. This 
implies that GlcCer is incorporated into the plasma membrane. Using two-photon 
imaging, our lab is currently setting-up a technique to visualize, whether the change 
in lipid stacking occurs uniformly within the plasma membrane or if micro domains 
are formed. Furthermore, this imaging technique will also allow us to analyze, 
whether lipid stacking of intracellular membranes is also affected by accumulation of 
GlcCer. In addition, we are studying the subcellular localization of GlcCer 
accumulation in GBA2 knockout-cells using immunogold-labelling in combination with 
electron microscopy [110] [111] [112]. Our final goal is to visualize GlcCer 
accumulation and the changes in the membrane composition not only in single cells, 
but also in testis sections. This will allow us to further determine how GlcCer controls 
cellular function.  
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5.2. How does GlcCer accumulation in GBA2 knockout-mice lead to 
globozoospermia?  
 One of the main questions that I wanted to answer during my PhD thesis was 
how GlcCer accumulation affects cytoskeletal dynamics, in particular in the testis. 
Does the altered lipid stacking at the plasma membrane directly influence the 
underlying cytoskeleton or does it disturb signaling cascades controlling cytoskeletal 
dynamics? The assembly, stability, and function of membrane proteins relies on 
protein-lipid interactions in the bilayer. The chain length of the lipids in the bilayer and 
the density of their packing controls the activity of membrane proteins [113]. This has 
been shown for different proteins. Activity of the Ca2+-ATPase, a calcium pump in 
skeletal muscle cells that transports Ca2+ ions across the ER membrane upon ATP 
hydrolysis, was low when the fatty acid acyl chains of the phospholipids surrounding 
the purified protein were shorter (C14) or longer (C20) than C16 – C18, the required 
chain length for optimal activity [114]. Furthermore, the activity was highest in the 
ordered phase of phospholipid packing and lower in the disordered phase [114]. The 
function of certain membrane proteins can be stimulated or inhibited by lipids acting 
as cofactors [115]. For the Ca2+-ATPase, binding of phosphatidylinositol-4-phosphate 
to the inner region of the transmembrane domain results in doubling of the ATPase 
activity [116], whereas binding of phosphatidylserine inhibits the ATPase 
activity [117].   
Glycosphingolipids have a propensity to form micro domains, which function 
as specialized signaling platforms [3]. The lipid raft hypothesis was proposed to 
explain the preferential segregation of glycosphingolipids to the apical region in 
polarized cells [18]. Lipid rafts are formed by the non-random assembly of membrane 
components such as cholesterol, proteins, and sphingolipids to form dynamic clusters 
also known as micro domains (Figure 22). Lipid rafts have been proposed to 
determine cell polarity, regulate signal transduction, sorting and trafficking of proteins 
through the secretory and endosomal pathway, to form platforms for adhesion of the 
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extracellular matrix and tethering of intracellular cytoskeletal proteins to the plasma 
membrane, and they also serve as entry points for viruses, bacteria, toxins, 
etc. [118] [119].  
 
 
Figure 22. Lipid-raft formation. Schematic representation of a lipid-bilayer membrane. The 
lipid raft domains contain tightly packed glycerophospholipids (GPL), glycosphingolipids 
(GSL), sphingomyelin (SM), membrane-anchored proteins, and transmembrane proteins 
(TM). The formation and maintenance of the rafts is also supported by the underlying actin 
cytoskeleton. Image taken from [120].  
 
How do glycosphingolipids control membrane-protein function? The activation 
of rafts for signal transduction involves protein-lipid interactions and a change in the 
membrane order within the lipid rafts (Figure 22) [120]. The function of growth factor 
receptor-associated protein kinases is modulated by gangliosides, complex 
glycosphingolipids that form a part of the rafts [121]. It has been shown that a change 
in membrane-lipid packing causes a direct interaction of the neuraminic acid in the 
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head group of the ganglioside GM3 (monosialodihexosylganglioside) with the 
membrane-proximal lysine of the epidermal growth factor (EGF) receptor kinase 
domain, thereby, inhibiting autophosphorylation of the intracellular tyrosine residues 
of the EGF receptor. This prevents receptor dimerization, rendering it inactive, 
thereby, attenuating uncontrolled signaling in the absence of the ligand. In contrast, 
the EGF receptor can be activated by autophosphorylation when cholesterol is 
depleted from the membrane [122]. Furthermore, in B16 mouse melanoma cells, 
increasing GM3 levels augments the activity of the focal adhesion kinase (FAK) and 
binding of GTP to Rho and Ras signaling molecules. As a consequence, B16 
melanoma cells spread and migrate faster [123]. Hence, the lipid environment plays a 
significant role in the regulation of membrane protein-function.  
How do membrane lipids and the cytoskeleton communicate? It is known that 
actin filaments can be directly bound to the plasma membrane via proteins like ERM 
(ezrin, radixin, and moesin) proteins, cellular prion protein, CIP4 (Cdc-42 interacting 
protein-4), IRSp53 (insulin receptor substrate protein-53kDa), caveolin-1, and 
filamin A [124] [125] [126] [119].  Furthermore, flotillin/reggie and TSPN7 
(tetraspannin-7) recruit actin-binding proteins to the plasma membrane that bind to 
the plasma membrane and also interact with the actin cytoskeleton [127] [119]. A 
prominent example for how changes in the lipid composition of the plasma 
membrane control cell function through the cytoskeleton is the activation and 
migration of T lymphocytes. Upon antigen binding to the T cell receptors, lipids in the 
membrane reorganize and lead to clustering of the receptors with cholesterol and 
glycosphingolipids, thereby forming part of the immunological synapse [128]. In turn, 
adhesion molecules and junctional proteins are recruited to the synapse, including 
proteins that control the actin cytoskeleton such as talin, vinculin, and ERM proteins. 
This initiates lymphocyte migration [128] [119]. Reciprocally, the actin cytoskeleton 
assists in reorganizing membrane lipids. The actin-binding protein filamin A which is 
also recruited to the immunological synapse controls reorganization of membrane 
lipids [129]. Hence, there seems to be a cross-talk between the lipids and proteins in 
membrane rafts and the cytoskeleton.  
Discussion 
 
69 | P a g e  
 
The actin cytoskeleton responds to stimuli by localized polymerization or 
depolymerization [126]. Actin is a globular protein (G-actin) with an ATP binding-site 
in the center of the molecule [130]. Dimerization or trimerization of G-actin serves as 
a site for nucleation and growth of the actin filament [131]. Actin filaments polymerize 
at the plus-end whereas depolymerization occurs at the minus end [131], a process 
known as actin treadmilling. Several classes of actin-binding proteins control the 
polymerization and depolymerization of F-actin. For example, profilin is a promoter of 
actin polymerization. It binds to G-actin, thereby, attracting more G-actin monomers 
and accelerating nucleation [132]. In contrast, actin-severing proteins, such as 
gelsolin and cofilin, clip existing F-actin filaments, causing depolymerization of actin 
filaments to regulate their length [133] [134]. Actin capping-proteins bind to the free 
ends of F-actin filaments to protect them from depolymerization [135]. Hence, actin 
dynamics are controlled via the activity of actin binding-proteins.  
  But how does GlcCer control actin dynamics? Which signaling pathways are 
affected by accumulation of GlcCer? Lipidomics revealed that in GBA2 
knockout-mice, glycosphingolipids with the C16 carbon-chain length were more 
abundant (Figure 11d, e). C16 ceramide has been shown to increase cell migration in 
embryonic stem cells by increasing actin polymerization [136]. C16 ceramide 
regulates PKC-dependent phosphorylation of FAK and paxillin, which leads to 
complex formation of Cdc-42, neural Wiskott-Aldrich syndrome protein (N-WASP), 
and the actin-related protein (ARP 2/3). This complex increases the interaction of the 
actin polymerizing proteins cofilin-1 and alpha-actinin-1/-4 with F-actin, thereby, 
facilitating F-actin elongation [136]. However, the authors did not examine whether 
the increase in C16 ceramide levels also increased the intracellular levels of GlcCer. 
Thus, these effects could also be due to an increase in C16 GlcCer levels. My results 
demonstrate that in particular the C16 GlcCer levels are increased in GBA2 
knockout-mice and that fibroblasts from GBA2 knockout-mice migrate faster. Thus, 
future studies will show, whether FAK activity and complex formation of N-WASP, 
Cdc-42, and ARP 2/3 is affected in GBA2 knockout-mice. Indeed, I have shown that 
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actin polymerization in GBA2 knockout-fibroblasts is increased, leading to the 
formation of filopodia and lamellipodia.  
The formation of filopodia and lamellipodia is controlled by the Rho GTPases 
Cdc-42 and Rac1, respectively, which locally activate actin polymerization [137] [91]. 
Filopodia are important for sensing the environment, axon guidance, and the 
formation of epithelial cell–cell contacts [138]. As described above Cdc-42 induces 
actin polymerization via N-WASP/ARP 2/3 complex formation [137]. However, 
Cdc-42 also induces actin polymerization via mDia2 (mammalian diaphanous 
protein 2), a member of the formin protein family [139]. Independent of Cdc-42 and 
Rac1, bundling of polymerized F-actin to form filopodia is mediated by fascin, an 
actin cross-linking protein [126]. Lamellipodia form the leading edge of migrating cells 
and actin polymerization at the lamellipodium is thought to drive membrane 
protrusion [140]. Rac1 mediates lamellipodia formation by inducing ARP 2/3 complex 
formation via WAVE (WASP-family verprolin-homologous protein) or mDia [91]. Rac 
proteins also regulate actin polymerization by increasing the availability of free 
F-actin ends either by removing the capping proteins or by severing actin filaments 
via cofilin and gelsolin [141]. Regulation of cofilin levels also replenishes the supply 
of actin monomers, thereby, facilitating actin polymerization [142]. Therefore, the 
temporal and spatial regulation of Rho GTPase activity is crucial for actin dynamics. 
In addition, it has been shown that effectors of Rho GTPases such as mDia stabilize 
microtubules in the leading edge of migrating cells [143]. Hence, interfering with the 
actin cytoskeleton can also have an impact on the microtubule cytoskeleton.  
Lipids have been shown to regulate Rho GTPase signaling [119]. Stimulation 
of dendritic cells with lipopolysaccharide (LPS) reorganizes the plasma membrane, 
thereby, recruiting Rac1 to lipid rafts [144]. Similarly, Cdc-42 is recruited to lipid rafts 
resulting in a rearrangement of the actin cytoskeleton, which controls cellular 
morphology and conditions dendritic cells to efficiently stimulate CD8+ receptors on T 
cells [144]. Also, it is known that phosphatidylinositol (3,4,5)-triphosphate (PIP3) 
generated by phosphoinositide 3-kinase (PI3K) activates Rac1 via Rac-GEFs [145] 
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and phosphatidylinositol (4,5)-diphosphate (PIP2) directly interacts with Cdc-42 and 
RhoA to stimulate the release of GDP [146].  My results indicate that the more 
ordered lipid packaging in the plasma membrane influences the activity of signaling 
molecules that regulate cytoskeletal dynamics. However, further experiments need to 
be performed to elucidate, whether the activity of Rho GTPases is affected in GBA2 
knockout-mice.  
Depending on the cell type, cytoskeletal defects in GBA2 knockout-mice have 
a different impact on cell function. Whereas in GBA2 knockout-fibroblasts, 
augmented actin polymerization and a higher microtubule persistence results in 
faster cell migration, in GBA2 knockout-testis, sperm-head formation is disturbed, 
reducing fertility. Sertoli and germ cells lack structures like lamellipodia and 
filopodia [95] [147] [148] [149]. However, during sperm development, the developing 
germ cells are transported towards the lumen of the seminiferous tubule with the help 
of Sertoli cells [150]. Here, the cytoskeleton plays an important role. The first check 
point is the BTB, a tight junction set up by adjacent Sertoli cells consisting of a 
dynamic network of actin filaments that undergo rapid bundling and debundling to 
facilitate the ‘opening’ and ‘closing’ of the BTB. Thus, spermatocytes can pass and 
are transported towards the lumen [151] [152]. The next check point is the apical ES, 
an adherence junction which has a slightly different protein composition compared to 
the BTB [40] [151] [153]. It has been proposed that the regulation of actin dynamics 
at the BTB and the apical ES relies on the activation of Rac1 and Cdc-42 [154]. 
Furthermore, Cdc-42 and Rac1 together with the N-cadherin-beta-catenin complex 
maintain the integrity of the adherence junction [113] [155]. Germ cell release from 
Sertoli cells into the lumen is initiated by the activation of RhoB GTPase through 
integrins at the apical ES. The following downstream activation of ROCK1 
(Rho-associated protein kinase 1), LIMK1 (LIM kinase 1), and cofilin disrupts the 
actin cytoskeleton at the apical ES resulting in germ cell release [95]. It has been 
shown that the function of integrins is different in ordered and disordered membrane 
phases [156]. Furthermore, changes in lipid environment also prevented formation of 
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the cadherin-catenin complex, compromising the function of the adherence 
junction [157].  
My results demonstrate that BTB integrity and function in GBA2 knockout-mice 
is not affected because germ cells are not prematurely released into the lumen. 
Rather the structure of the apical ES is severely compromised (Figure 13). We have 
shown that GBA2 is attached to the membranes of the ER, which in the Sertoli cells, 
forms a part of the apical ES [57]. Thus, GBA2 could regulate GlcCer levels at the 
interface between Sertoli and germ cells. In turn, in GBA2 knockout-mice, GlcCer 
might accumulate in the membranes at the ES, causing a more ordered lipid stacking 
and, thereby, affecting signaling in the ES, e.g. the function of Rho GTPases or the 
N-cadherin-beta-catenin complex (to mention a few examples). Consequently, the 
tightly regulated process of recruitment and activation of actin-binding proteins at the 
ES is impaired, resulting in misalignment of actin filaments around the sperm heads. 
This would explain how actin dynamics at the ES are altered when GlcCer 
accumulates. 
Furthermore, in the sperm manchette of GBA2 knockout-mice microtubule 
persistence is augmented. This could be due to a mis-regulation of the signaling 
molecules that control both the actin and microtubule cytoskeleton. GlcCer has also 
been shown to control vesicle transport and fusion [18]. My results underline this 
finding, demonstrating that accumulation of GlcCer during spermatogenesis hinders 
vesicle fusion and, thereby, acrosome formation, generating sperm with a round head 
and devoid of a well-formed acrosome (Figure 23). Future experiments will reveal, 
which signaling molecules are affected by GlcCer.  
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Figure 23. Sperm-head shaping in wild-type and GBA2 knockout-mice. Left: Schematic 
representation of the apical junction (ES) between a wild-type sperm head and a Sertoli cell. 
F-actin at the apical ES (green) from the Sertoli cell and the microtubule manchette (red) 
from the spermatid jointly shape the sperm head. As a result, sperm heads are sickle-shaped 
with a well formed acrosome (orange). The nucleus and the flagellum are indicated in grey 
and brown respectively. Right: see left for GBA2 knockout-sperm. Accumulation of GlcCer 
levels alters the lipid stacking at the ES (purple) which disrupts F-actin alignment and 
renders the microtubules of the manchette more persistent. Thereby, the sperm head is 
deformed causing globozoospermia.  
 
5.3. Novel role for GlcCer 
Apart from the known functions of GlcCer mentioned in chapter 1.2, my work 
demonstrates for the first time that GlcCer controls cytoskeletal dynamics and, 
thereby regulates, spermatogenesis in mice. Recently, it was reported that patients 
carrying a mutations in the GBA2 gene are infertile due to bilateral testicular 
hypertrophy with severe sperm-head deformation and motility defects [35]. However, 
the main clinical symptoms of these patients were cerebellar ataxia and severe 
hereditary spastic paraplegia with varying degrees of cerebellar and corpus callosum 
atrophies [158] [35]. So far we have not observed major neurological defects in GBA2 
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knockout-mice, although GBA2 is highly expressed in the brain. Studies performed 
by a master student in our lab revealed that the mutations found in patients with 
cerebellar ataxia and severe hereditary spastic paraplegia are dead mutants (Master 
thesis, Carina Marx). Thus, we analyzed locomotor function of GBA2 knockout-mice 
in more detail using behavioral studies. Preliminary results suggest that muscle 
strength in GBA2 knockout-mice is severely impaired (Master thesis, Carina Marx). 
Similarly, a study in zebrafish demonstrated that down-regulation of GBA2 
expression affected locomotion and reduced axon outgrowth of motor neurons [35]. 
Axon growth crucially relies on actin and microtubule function [159]. In future studies, 
we will investigate if GlcCer also accumulates in motor neurons of GBA2 
knockout-mice, thereby, affecting cytoskeletal dynamics and axon growth. 
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7. Appendix   
 
 
     1   M V T C V P A S E Q V G C A E R D S Q V Y C E D T G G T E A V R V T D C G S P E D S G P Q D E P S 
Y 
    51   C N S E D S G Q L M A S Y E G K A R G Y Q V P P F G W R I C L A H E F A E K R R P F Q A N N I S L 
S 
   101   N L V K H L G M G L R Y L K W W Y R K T H V E K K T P F I D M L N S L P L R Q I Y G C P L G G I G 
G 
   151   G T I T R G W R G Q F C R W Q L N P G M Y Q H Q T V I A D Q F I V C L R R D G R T V Y Q Q V L S L 
E 
   201   L P N V L R S W N W G L C G Y F A F Y H A L Y P R A W T V Y Q L P G Q N V T L T C R Q V T P I L P 
H 
   251   D Y Q D S S L P V G V F V W D V E N E G D E T L D V S I T F S M R N G L G G E D D A A G S L W N E 
P 
   301   F R L E Q G G T T V Q G L L L H H P T P P N P Y T M A V A A R C T A D T T V T H T T A F D P N G T 
G 
   351   Q Q V W Q D L L Q D G Q L D S P A G Q S T P T Q K G E G I A G A V C V S S K L L P R S R C C L E F 
S 
   401   L A W D M P K I M F G A K S Q V H Y R R Y T R F F G S D G D V A P A L S H Y A L C H Y A D W E D R 
I 
   451   S A W Q N P V L D D R T L P A W Y K S A L F N E L Y F L A D G G T V W L E V P A D S L P E G L G G 
S 
   501   M R Q L R S T L Q D Y G R F G Y L E G Q E Y R M Y N T Y D V H F Y A S F A L V M L W P K L E L S L 
Q 
   551   Y D M A L A T L K E D L T R R R Y L M S G V V A P V K R R N V I P H D I G D P D D E P W L R V N A 
Y 
   601   L I H D T A D W K D L N L K F V L Q I Y R D Y Y L T G D Q G F L E D M W P V C L A V M E S E M K F 
D 
   651   K D Q D G L I E N G G Y A D Q T Y D A W V T T G P S A Y C G G L W L A A V A V M V Q M A V L C G A 
Q 
   701   D V Q E R F A S I L C R G R E A Y E R L L W N G R Y Y N Y D S S S H P Q S R S I M S D Q C A G Q W 
F 
   751   L R A C G L G E G D T E V F P T L H V V R A L Q T I F E L N V Q A F A G G A M G A V N G M H P H G 
V 
   801   P D R S S V Q S D E V W V G V V Y G L A A T M I Q E G L T W E G F R T A E G C Y R T V W E R L G L 
A 
   851   F Q T P E A Y C Q Q Q V F R S L A Y M R P L S I W A M Q L A L Q Q Q Q H K K S R R P S V T Q G T G 
L 
   901   S T Q P E C G P K R S L A N L N S E 
Figure 24. Mass spectrometric detection of GBA2 in testis of mouse. Five 
different peptides from the GBA2 protein-sequence were chosen and using mass 
spectrometry their presence in the testis and Sertoli cells was detected. Four of the 
chosen peptides were present in testis (indicated in blue) and 2 peptides appeared in 
the Sertoli cells. However, 1 peptide was present in both testis and Sertoli cells 
(indicated in red and blue).    
 
               Peptide 1 
1   MVTCVPASEQVGCAERDSQVYC-EDTGGTEAVRVTDCGSPEDSGPQDEPSYCNSEDSGQL 59 
 
60  MASYEGKARGYQVPPFGWRICLAHEFAEKRRPFQANNISLSNLVKHLGMGLRYLKWWYRK 119 
 
120 THVEKKTPFIDMLNSLPLRQIYGCPLGGIGGGTITRGWRGQFCRWQLNPGMYQHQTVIAD 179 
 
180 QFIVCLRRDGRTVYQQVLSLELPNVLRSWNWGLCGYFAFYHALYPRAWTVYQLPGQNVTL 239 
 
240 TCRQVTPILPHDYQDSSLPVGVFVWDVENEGDETLDVSITFSMRNGLGGEDDAAGSLWNE 299 
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300 PFRLEQGGTTVQGLLLHHPTPPNPYTMAVAARCTADTTVTHTTAFDPNGTGQQVWQDLLQ 359 
          Peptide 2 
360 DGQLDSPAGQSTPTQKGEGIAGAVCVSSKLLPRSRCCLEFSLAWDMPKIMFGAKSQVHYR 419 
 
420 RYTRFFGSDGDVAPALSHYALCHYADWEDRISAWQNPVLDDRTLPAWYKSALFNELYFLA 479                     
        Peptide 3 
480 DGGTVWLEVPADSLPEGLGGSMRQLRSTLQDYGRFGYLEGQEYRMYNTYDVHFYASFALV 539 
 
540 MLWPKLELSLQYDMALATLKEDLTRRRYLMSGVVAPVKRRNVIPHDIGDPDDEPWLRVNA 599 
 
600 YLIHDTADWKDLNLKFVLQIYRDYYLTGDQGFLEDMWPVCLAVMESEMKFDKDQDGLIEN 659 
 
660 GGYADQTYDAWVTTGPSAYCGGLWLAAVAVMVQMAVLCGAQDVQERFASILCRGREAYER 719 
             Peptide 4 
720 LLWNGRYYNYDSSSHPQSRSIMSDQCAGQWFLRACGLGEGDTEVFPTLHVVRALQTIFEL 779 
 
780 NVQAFAGGAMGAVNGMHPHGVPDRSSVQSDEVWVGVVYGLAATMIQEGLTWEGFRTAEGC 839 
                                                    
840 YRTVWERLGLAFQTPEAYCQQQVFRSLAYMRPLSIWAMQLALQQQQHKKSRRPSVTQGTG 899 
 
900 LSTQPECGPKRSLANLNSE  918 
 
 
Figure 25. Mouse GBA2 protein-sequence with epitopes for the generation of 
antibodies indicated. The four peptides that were used to generate monoclonal 
antibodies are indicated in red and the epitope used to generate a polyclonal 
antibody is indicated in black.  
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